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Abstract
Introduction: Transient ischemic attack (TIA) is characterized by temporary neurological
dysfunction and carries a short-term risk of stroke, hospitalization, and death. Cardiac
rehabilitation and secondary prevention (CRSP) involving behavior change and exercise
reduces morbidity and mortality among heart patients but is typically not offered after TIA,
despite similarities in risk factors between coronary artery disease and stroke. Current stroke
secondary prevention strategies are suboptimal.
Objectives: To quantify the relationship between exercise adherence and functional capacity
at CRSP exit among exercise-trained TIA and mild non-disabling stroke (MNDS) patients
and to determine if CRSP improves physical and psychological outcomes.
Methods: From 2004 to 2014, 115 exercise-trained TIA/MNDS across three studies were
used for this study. Linear regression was used to analyze the primary objective and paired ttests were used to compare intake and exit measures of the secondary objectives.
Results: There was a positive relationship between exercise attendance and improvement in
functional capacity and the participants had clinically significant improvements in key
cardiovascular risk factors and psychometrics.
Conclusion: This study illustrated a “dose-response like” relationship between exercise
attendance and functional capacity that reached a clinically significant improvement of 0.5
METS (Canadian Cardiovascular Society quality indicator). Future work should investigate
the long-term impact of CRSP for TIA/MNDS patients as well as cost-effectiveness analyses.

Keywords
Transient ischemic attack; mild non-disabling stroke; cardiac rehabilitation; functional
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Summary for Lay Audience
A transient ischemic attack (TIA) often called a mini-stroke serve as an important warning
sign for future vascular events. TIAs have a short-term risk of stroke, hospitalization and
death. Current stroke prevention strategies are spread across multiple organizations and the
clinical practice is variable. Cardiac rehabilitation and secondary prevention (CRSP) is a
program offered to heart patients that is designed to improve their cardiovascular health. The
problem is that cardiac rehabilitation is not typically offered to TIA patients despite the fact
that they share similar risk factors. This study aimed to investigate the relationship between
exercise attendance and exercise capacity among exercise-trained TIA and mild-nondisabling
stroke (MNDS) patients enrolled in CRSP. It also aimed to determine if CRSP for
TIA/MNDS patients improves their physical and psychological outcomes. We selected 115
exercise-trained TIA/MNDS patients that were a part of three studies that occurred between
2004 and 2014 to conduct the statistical analyses. We found that there was a positive
relationship between exercise attendance and improvement in exercise capacity.
Additionally, exercise trained TIA/MNDS patients had clinically significant improvements in
cardiovascular risk factors and psychological outcomes. In conclusion, we observed a “doseresponse like” relationship between exercise attendance and exercise capacity and we
observed favourable outcomes that reached clinically significant improvements. Our findings
suggest that CRSP may be a more effective means for secondary prevention for this patient
population.
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Chapter 1
1

Introduction

This chapter explores the prevalence of cardiovascular diseases and stroke globally and
specifically the prevalence of stroke in Canada. It also defines transient ischemic attack and
summarizes Cardiac Rehabilitation and Secondary Prevention (CRSP) components and
benefits. Lastly, this chapter discusses the purpose of this thesis, objectives and the thesis
outline.

1.1 Overview
Cardiovascular diseases are one of the leading causes of death worldwide (1), and stroke is
the second leading cause of mortality globally (2). Stroke has an estimated global lifetime
risk of 24.9% starting at age 25 (3). In Canada, the third leading cause of death is stroke (4).
Stroke costs the Canadian economy more than $3.6 billion a year in physician services,
hospital expenditures, loss of individual income, and diminished productivity. A similar
impact can be observed among individuals who have experienced a minor stroke or transient
ischemic attack (TIA)(5). TIAs also known as mini-strokes carry a short-term risk of stroke,
hospitalization, and death (6), but the risk of subsequent events can be reduced by behavioral
risk modification (7). Therefore, the chance to prevent recurrent stroke through risk factor
modification efforts signifies a meaningful opportunity to reduce the stroke burden.
Cardiac Rehabilitation and Secondary Prevention uses a multidimensional approach that
includes: reducing cardiovascular disease risk factors, using behavior modification strategies
to maintain healthy lifestyles, promote pharmacological adherence, and provide therapeutic
exercise training (8). Clinically, secondary prevention is designed to stop or slow progression
of a disease of disorder when patients have a disease and are at risk for developing something
related to their current disease (9). CRSP is typically delivered through a case-managed
comprehensive model of secondary disease prevention to individuals with cardiovascular
disease including those who have experienced a myocardial infarction, angina or heart
surgery (8). CRSP has been proven to reduce morbidity and mortality among patients with
known heart disease (10) but is typically not offered to TIA or mild stroke patients despite
the many parallels in risk factors between heart disease and stroke. Current research suggests
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that in these patients, programs like CRSP may be a more effective means of reducing
cardiovascular risk and improving quality of life than standard care. It has been demonstrated
that it is feasible and safe for TIA patients to partake in CRSP and it is clear that current
secondary prevention strategies for stroke care are suboptimal (11).

1.2 Purpose and Objectives
This thesis provides further evidence of the degree to which individuals with TIA can benefit
from a CRSP program. Our primary research question was: how does exercise attendance in
CRSP influence TIA/MNDS patient’s functional capacity? The primary objective for this
project was to quantify the relationship between exercise adherence (attendance) and
functional capacity (measured in METS) at CRSP program exit among exercise trained TIA
and mild non-disabling stroke (MNDS) patients. The secondary objectives were to: 1)
determine whether CRSP programming among exercise trained TIA/MNDS patients resulted
in intake-to-exit improvements in functional capacity, blood pressure, lipid profile, blood
glucose, body measurements and composition and 2) determine whether CRSP programming
among exercise trained TIA/MNDS patients results in significant intake to exit changes in
the following psychometric domains: quality of life and health status, anxiety, depression,
general cognitive functioning, attention and working memory, verbal learning and memory,
pre-morbid intellectual functioning and speed/executive/abstraction.

1.3 Thesis Outline
The following chapter - Chapter 2 includes a review of the literature. A detailed description
of study objectives and hypotheses for this project are then provided in Chapter 3. Study
methodology is covered in Chapter 4. The results are reported in Chapter 5, with a discussion
section reported in Chapter 6.
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Chapter 2
2

Review of the Literature

The literature review provided in Chapter 2 includes ten sections. Section 2.1 explores the
changing definitions of transient ischemic attack from the 1960s to present day, then Section
2.2 outlines the modifiable, and non-modifiable risk factors for TIA/MNDS. Section 2.3
explores the current treatment strategies for TIA/MNDS. Sections 2.4, 2.5, and 2.6
summarizes literature investigating cognitive impairment among the TIA and minor stroke
population, current evidence on depression and anxiety among this patient population, and
research investigating quality-of-life among TIA and minor stroke patients respectively.
Section 2.7 defines and describes the components and benefits of CRSP while Section 2.8
summarizes studies that have investigated TIA/MNDS in a CRSP or CRSP-like setting and it
is organized by type of study. Lastly, Section 2.9 outlines the benefits of exercise training
and Section 2.10 outlines the gaps in the literature.

2.1 Transient Ischemic Attack
A transient ischemic attack (TIA), also known as a mild non-disabling stroke (MNDS) or
mini-stroke is characterized by temporary neurological dysfunction caused by loss of blood
flow in the brain, spinal cord or retina without tissue death (12). There is a long-standing
time-based definition for TIA – which is cerebral ischemia in which symptoms last less than
24 hours. This definition originated from the 1960s and was used for about 40 years (12).
The time-based definition was developed at a time where there were very few options
available for stroke prevention or treatment, and little understanding of stroke risk factors
(13). Recently, research advances have illustrated that the time-based definition maybe
erroneous, confusing, and could potentially impact patients’ outcomes due to the initiation of
treatment being delayed. Therefore, the time-based definition has shifted to the tissue-based
one so that patients with transient neurological deficits of vascular origin with imaging
evidence of acute ischemia are more likely to be diagnosed as “minor stroke” (14), and
therefore require treatment (13).
TIAs are an important warning sign for further, more devastating vascular events or death
(6). A TIA and ischemic stroke share common pathophysiological mechanisms (15) and
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individuals who have suffered from a TIA may also experience cognitive impairment similar
to patients with major stroke (7). Recent meta-analyses of individuals with TIA revealed that
the short-term risk of stroke after TIA was 10% within the first 48 hours and between 9% to
17% at 90 days (16). Among individuals who present with stroke, the prevalence of a prior
TIA has been reported to range from 7% to 40% (12). The risk of subsequent stroke
following a TIA can be reduced by risk factor modifications (17).

2.2 Risk Factors
There are modifiable and non-modifiable risk factors for TIAs. Modifiable risk factors
include: hypertension, diabetes, hyperlipidemia, cigarette smoking, excessive alcohol
consumption, obesity, physical inactivity, metabolic syndrome (18), depression (19), and
socioeconomic status (SES) (20). Non-modifiable risk factors include age, family history,
sex, and ethnic origin (21).

2.2.1 Modifiable Risk Factors
Being physically inactive can increase the risk of stroke and heart disease (22). The
protective effect of habitual exercise has been shown to have a number of benefits on key
risk factors such as hypertension, dyslipidemia, diabetes, physical inactivity, obesity,
excessive alcohol intake, and tobacco use (23). The relationship between increased physical
fitness and reduced risk for TIA/stroke is described in more detail in section 2.9.
Hypertension is defined as systolic blood pressure ≥ 140 mm Hg or diastolic blood pressure
≥ 90 mm Hg (24). Hypertension is a major risk factor for cerebral infarction and
intracerebral hemorrhage, and the risk of stroke increases with high blood pressure (21).
Diabetes mellitus is an independent risk factor for stroke and it has been found to more than
double the risk of stroke. Individuals with diabetes mellitus are more susceptible to
atherosclerosis and have an increased prevalence of other atherogenic risk factors such as
hypertension and dyslipidemia (21). Abnormally elevated levels of total cholesterol or low
density lipo-protein cholesterol (LDL-C) have been found to be associated with an increased
risk of ischemic stroke, and higher levels of high-density lipoprotein cholesterol (HDL-C)
have been reported to be associated with decreased risk of stroke (22). Recent
epidemiological data suggests that the relationship between HDL-C and all-cause mortality is
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U shaped, suggesting that very high and low concentrations are associated with high allcause mortality (25). Furthermore, there is strong and consistent evidence that cigarette
smoking is a risk factor for ischemic stroke (26). Additionally, exposure to environmental
smoke (27) or passive smoking (28) is also an established risk factor for heart disease and
stroke. The American Heart Association reports that cigarette smoking approximately
doubles the risk of stroke (21).
There is strong evidence between heavy alcohol consumption and all stroke subtypes,
although there is limited evidence investigating the effect of alcohol consumption and
recurrent stroke. It is possible that any elevated risk of recurrent stroke would be resulting
from the interrelationship alcohol consumption has with other stroke risk factors (e.g.
alcohol-induced hypertension) (18,29). Obesity has been established as an independent risk
factor for cardiovascular disease and stroke. However, the association between body weight
and stroke has been mostly investigated in primary prevention studies (18). A large body of
evidence suggests a graded positive association between obesity and stroke independent of
other cardiac risk factors, but it remains unknown whether weight loss reduces the risk of
stroke or recurrent stroke due to the other effects weight loss can have on other risk factors
such as diabetes and hypertension (21).
A positive relationship between depressive symptoms and stroke mortality has been reported.
After adjustment of other well-known stroke risk factors, it was found that individuals
reporting five or more depression symptoms at baseline experienced greater than 50% excess
risk of mortality due to stroke during the following 29 years (19). SES has also been found to
be associated with stroke. It has been observed that stroke disproportionately affects lowincome and middle-income countries (30) but also low-SES groups in high-income countries
and such disparities are found in the risk of stroke and the long-term effects after stroke
(20,31). Several studies on general populations in developed countries have shown a higher
prevalence of common stroke risk factors in low-SES groups. Specifically, in the NHANES I
study conducted in the USA, they reported that smoking, heart disease, physical inactivity,
use of blood pressure medications and high SBP was highest among white men in the lowest
poverty-index-quartile (32).
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2.2.2 Non-modifiable Risk Factors
With greater age, the risk of stroke increases (33). There is an accumulation of risk factors
with age due to the aging cardiovascular system and the progressive nature of stroke risk
factors (21). The rate of stroke is reported to double every ten years after the age of 55 (34).
The risk of stroke may be greater with a family history of TIAs or stroke. It has been reported
that having a positive family history of stroke increases the risk of stroke by approximately
30% (21). Generally, stroke is more common in men or women at different time periods
(22). Women experience stroke later than men potentially because of loss of protection by
estrogen after menopause (35). There are racial and ethnic differences found in TIA
prevalence and stroke mortality. Blacks and some Hispanic/Latino American’s have a
greater incidence of all stroke types and higher mortality compared to whites (21).

2.3 Treatment
The current treatment strategies for TIA primarily include the prescription of antiplatelet or
anticoagulation agents and blood pressure and cholesterol-lowering medications (16). Nonpharmacological interventions that could play a role in secondary prevention after TIA
include exercise, dietary advise, lifestyle counselling, and patient education (36). Exercising
has significant health benefits on blood pressure, plasma lipoprotein status, weight loss and
glycemic control. Additionally, education programs tailored towards exercise and diet have
been found to reduce plasma fasting glucose among individuals at high risk for type 2
diabetes (36). These non-pharmacological interventions are aimed to reduce vascular risk
factors which is a multifaceted problem that requires intervention at various levels. There are
stroke prevention clinics tailored to provide individuals with access to stroke specialists and
diagnostic tests, risk factor screening and referrals to outpatient services as needed. These
secondary prevention programs tend to be spread across multiple organizations and the
clinical practice is variable and often suboptimal (11). Stroke prevention clinics were
established in Ontario is 2001. The Ontario Stroke Evaluation Report 2013: Spotlight on
Secondary Stroke Prevention and Care suggested that there is room for improvement in the
standardization protocols for achieving best practices across the entire network of clinics
(37).
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2.4 Cognitive Impairment in TIA and Minor Stroke
Conventionally, healthcare professionals and individuals have considered a TIA to be a
relatively non-threatening event compared to the disabling characteristics of stroke (12).
Despite the resolution of symptoms from a TIA, advances in neuroimaging have shown
evidence of infarction in about one third of patients post-TIA (18). Individuals with TIA or
ischemic stroke have an increased risk of developing cognitive impairment (38). However,
there is a limited amount of research exploring cognitive impairments after a TIA. Cognitive
impairments are known to occur after major stroke with a prevalence that varies from 20% to
90% (7). These cognitive impairments are potential sequelae of TIA and minor stroke (38). A
recent study reported that most individuals who had a TIA or minor stroke showed deficits in
cognitive control or executive function with 57% of the patient population impaired in one or
more of the neuropsychological tests employed (39). Compromised executive function can
be characterized by troubles in working memory, reasoning, task flexibility, and problem
solving (13).
Cognitive deficits due to diseases of vascular origin are well documented in the literature.
“Vascular cognitive impairment” and “vascular dementia” are terms used to describe a
variety of mild to severe cognitive deficits that are caused by stroke or subclinical vascular
brain damage (13). Vascular cognitive impairment is predictive of hospitalization, mortality,
and dementia (40). Ganzer et al (2016), suggested that the effects of vascular risk factors
such as type 2 diabetes and high diastolic blood pressure can be associated with changes in
executive function and contribute to the occurrence of transient cognitive impairment (TCI)
post TIA. Additionally, these vascular risk factors in TIA patients increase the risk of
progression of white matter hyperintensities, which are related to cognitive decline (41).
Additionally, there are shared risk factors between TIA and cognitive function such as
advanced age that are associated with cognitive decline.
The frequency of cognitive impairment following a TIA or minor stroke is influenced by the
measurement tool used. A systematic review investigating prevalence of cognitive
impairment among other psychological outcomes following TIA and minor stroke reported
prevalence of cognitive impairment of 17% (95% CI 7,26), 39% (95% CI 28,50), and 54%
(95% CI 43,66) using the Mini Mental State Examination (MMSE), Neuropsychological Test
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Battery (NTB), and Montreal Cognitive Assessment (MoCA) respectively (38). A recent
systematic review by van Rooiji Frank et al., (2016) investigating the prevalence of cognitive
impairment in TIA patients and potential causative factors reported a highly variable rate of
mild cognitive impairment after TIA ranging from 29% to 68% and severe cognitive
impairment in 8% to 22% of the patients (12 studies, n=1,167). The modes of testing
included the NTB, MoCA, Modified Telephone Interview for Cognitive Status (TICSm), and
MMSE. The researchers also found that deficits in executive function, attention, and
information processing speed were most common and suggested that the rate of cognitive
impairment was likely higher in the total population with TIA since their patient population
was only limited to individuals without dementia (41).
Furthermore, a study investigating TCI defined as “acute cognitive deficits demonstrated
early after major stroke that may recover to some extent in TIA and minor stroke at the time
of initial assessment and one month later”, found that the rate of TCI was higher in cerebral
TIA and stroke patients that were seen acutely (1 to 7 days after their presenting event) than
those seen after 7 days. A higher rate of TCI was also found in TIA and stroke patients seen
acutely versus non-cerebrovascular patients (42). Follow up for the individuals who survived
to five years within the same patient population illustrated a higher rate of cognitive
impairment in those with TCI versus those without. The authors concluded that, TCI was
common after minor cerebrovascular events, was occult in the majority of patients, and was
associated with subsequent cognitive decline (42).
In another study, by van Rooiji Frank et al., (2014) among TIA patients without a prior
history of stroke or dementia within 3 months of the event (n=188), they found that
individuals with TIA performed worse than controls on cognitive tests and domains that
measured executive function, information processing speed, working memory, and attention.
The opposite trend was observed for episodic memory that remained preserved (43). Among
the patient population, silent brain infarct (SBI) but not age-related white matter changes
were associated with poorer executive functioning. When patients with SBI were excluded,
TIA was still found to be associated with impaired cognition. The authors concluded that
future studies should utilize brain imaging techniques in combination with long-term
cognitive assessment to identify whether the cognitive effects are transient, stationary, or
progress over time. In a study by Sachdev et al, (2014) investigating the progression of
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cognitive impairment in stroke/TIA over 3 years it was found that patients did not typically
decline more than controls in most cognitive domains, but they had lower baseline measures.
Patients with interval stroke/TIA had a significantly greater decline than controls in attention,
processing speed, working memory, visuoconstruction, mental flexibility, and verbal fluency.
Patients without interval stroke/TIA declined more only on verbal memory (44). The authors
concluded that stroke/TIA patients who do not experience interval stroke/TIA have a slow
cognitive decline compared to patients who experienced another stroke or TIA during follow
up.
An exploratory study investigating patients with TIA or minor stroke’s cognitive and
communication problems six months after the event compared to patients with angina
pectoris, found that TIA and minor stroke patients had deficits in memory (n=24) and/or
concentration (n=14). The communication problems were mainly attributed to difficulties in
writing and speech and language comprehension and TIA and minor stroke patients reported
significantly more difficulties than angina patients (45). Prior et al., (2017) found that
frequencies in executive impairments between entry and exit to CRSP remained unchanged
and suggested that such impairments were persistent 10 months post TIA/MNDS (46). These
findings further support that TIA and minor strokes effects are not as transient as we believed
and that this patient population would likely benefit from care after hospitalization.
Overall, cognitive impairment is an important issue in TIA patients, which further justifies
research investigating this patient population at high risk of cognitive decline. These
unresolved deficits of cognitive functioning after TIA could impact an individuals’ ability to
learn and understand new information, along with the application of health behaviours
intended to reduce vascular risk factors (13). Additionally, these deficits put this patient
population at greater future risk of progressive cognitive decline and possibly leading to
dementia (47). It has been suggested that multi-domain interventions that include diet,
exercise, cognitive training and vascular risk factor monitoring could result in improvement
or maintenance of cognitive functioning in the elderly population (48). Thus, further research
is in this subject area is needed.
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2.5 Depression and Anxiety Among TIA and Minor Stroke
Patients
One in three stroke survivors are affected by depression (23,49) and one in four survivors
develop post stroke anxiety (49). The pathophysiological mechanisms of post-stroke
depression are thought to be multifaceted and influenced by location and magnitude of brain
injury, vascular comorbidities and coping with emerging functional disabilities (50). Other
studies have suggested that small-vessel brain disease resulting from long-lasting ischemic
changes in the brain maybe involved in the pathogenetic pathway of late-life depression (51).
Generally, post-stroke psychological outcomes are fairly under researched compared to
physical disabilities associated with stroke. Furthermore, there are not many studies that have
examined mood disorders in TIA samples. It is possible that psychological effects of TIA
maybe similar to that of stroke survivors.
A study by Broomfield and colleagues investigating the prevalence of depression and
anxiety using a regional stroke registry in the United Kingdom found that out of 1247 TIA
cases reviewed, 179 (14%) and 107 (9%) of cases were classified as definite abnormal
anxiety and definite abnormal depression symptoms respectively (49). The authors also
investigated cases in a stroke cohort and found that depression and anxiety levels were
similar between the TIA and stroke patients. Their data suggested that depression and anxiety
symptoms are common following stroke events including TIA, and interventions and
psychological assessments should not be limited to stroke patients only. Similar findings
were reported in a study by Husseini et al. (2012) investigating depression and antidepressant
use after stroke and TIA. The authors found that the proportional frequency of depression
was similar with stroke and TIA patients at 3 months (17.9% versus 14.3%) and at 12 months
(16.4% versus 12.8%) (50). Additionally, the proportion of antidepressant use, and incident
antidepressant use was also similar between stroke and TIA patients. Younger age, poor
functional outcome, depression, and inability to work at three months was associated with
post-stroke depression at 12 months. Prior et al., (2017) found that at CRSP exit 16.9% of the
cohort (n= 70) screened positively for anxiety, which suggested that clinically important
levels of anxiety may persist 10 months post event despite treatment, and that further
research is merited to determine optimal treatment for this patient population (46).
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A recent systematic review found that the prevalence of depression was high within the first
month after TIA or minor stroke and decreased between six weeks and three months.
Furthermore, there were no significant differences in the prevalence of depression between
TIA or minor stroke patients (38). The authors reported a prevalence of anxiety of 52% and
65% for TIA and minor stroke participants respectively, but these findings were observed
from only one study. The findings suggested that the prevalence of depression was high in
the acute stage after TIA or minor stroke but appeared to decrease over time.
Maaijwee et al., (2016) investigated the long-term depressive symptoms and anxiety after
TIA or minor stroke in young adults (<50). The overall prevalence of depression and anxiety
for TIA and minor stroke patients was 16.8% and 23% respectively. The prevalence of
depression and anxiety was higher than their age and sex matched controls. For individuals
with TIA, the prevalence of depression and anxiety symptoms was 12.1%. and 23.1%
respectively (52). These findings showed that individuals who experienced stroke at a young
age where influenced by psychological outcomes of stroke even 10 years after stroke. These
individuals with TIA or ischemic stroke were at risk of depressive symptoms and anxiety of
about five times greater than stroke free controls. A similar study investigating TIA and
incident depression found that in 325 persons with TIA, about 8% developed depression, and
after 12 years of follow-up, twice as many individuals with TIA developed depression (53).
Interestingly, TIA was more strongly associated with depression the more strictly depression
was defined. These findings further confirm the high risk of post-TIA depression and anxiety
and justifies the greater need to pay attention to these psychological outcomes within this
patient population.

2.6 Quality of Life in Patients with TIA and Minor Stroke
It is widely known that acute ischemic stroke leads to a decline in an individuals’ healthrelated quality of life (HRQOL), even among individuals who have minimal or no strokerelated deficits (54). It is possible that emotional changes after a stroke event would have an
effect on quality of life (QOL), and this may in turn influence how an individual copes,
adapts, and overcomes the challenges associated with the event (55). The prevalence of
depression is high among stroke patients, and such post-stroke depression decreases QOL
among this patient population (53). Additionally, unrecognized cognitive dysfunction may
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also affect an individual’s QOL (41). Specifically, impaired executive function can manifest
as issues in memory, reasoning, task flexibility, and problem solving which are all factors
that can affect one’s QOL and their capacity to deal with post-stroke medical challenges (13).
Despite TIA/MNDS’s transient nature, they still exhibit important psychological
ramifications, including depression and anxiety (55) and diminished QOL (56).
In a study by Sangha et al, (2015) investigating the quality of life of patients with TIA and
minor ischemic stroke at three months, the patients completed a series of domain-specific
HRQOL assessments using five Neuro-QOL measures: upper extremity function, lower
extremity function, satisfaction with social roles and activities, applied cognition-executive
function, and applied cognition-general concerns. Out of 332 patients, any HRQOL
impairment was found in 119 patients (35.8%), and stratified analysis showed a statistically
significant difference between index stroke with more impairments in individuals with mild
ischemic stroke compared to TIA (39.7% vs. 22.7%, p<0.001) (54). The authors concluded
that impairment in HRQOL is common three months following mild ischemic stroke and
TIA, and this is observed in patients without disability. Additionally, age, index stroke
severity, and recurrent strokes were predictors of compromised HRQOL. They also
suggested that Neuro-QOL measures should be employed after TIA and mild ischemic stroke
as they may aid in the identification of mild deficits in this patient population (54).

2.7 Cardiac Rehabilitation and Secondary Prevention
Cardiac rehabilitation and secondary prevention (CRSP) is a program that is a component of
cardiovascular disease care and chronic disease management (57). CRSP delivers a casemanaged comprehensive model of secondary disease prevention to individuals with known
heart disease – for example, those who have had a heart attack, angina, or heart surgery (8).
CRSP uses a multidimensional approach that includes: reducing cardiovascular disease risk
factors, using behaviour modification strategies to sustain healthy lifestyles, promote
pharmacological adherence, and provide therapeutic exercise training (8). The current body
of knowledge suggests that there is an association between CRSP program participation, and
each of improved exercise capacity, obesity indices, lipid profiles, quality of life, reduced
inflammation, psychological distress and most notably reductions in mortality and morbidity
(58).
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There are approximately 220 CRSP programs in Canada, providing services to more than 50
000 new patients annually (59). In Ontario, this program is not typically offered to TIA
patients although there has been compelling evidence that this multidimensional approach as
secondary prevention strategy after TIA was effective and feasible for TIA and MNDS
patients (60,61). A survey found that 24 (60%) of the 40 facilities from the Cardiac
Rehabilitation Network of Ontario Directory indicated that the CR program enrolled
individuals with stroke (62). However, of the 18 facilities that provided more detailed
responses, stroke participants represented only 4.8% of their total annual enrolment.

2.8 Cardiac Rehabilitation for TIA and Mild-Non-Disabling
Stroke Patients
There are many shared risk factors between heart disease and stroke yet despite the
demonstration of the benefits of risk factor modification interventions such as CRSP, these
strategies are not a priority in current stroke practice (62). There is emerging evidence that
such a strategy results in improvement of key stroke risk factors.

2.8.1 Observational Studies
Many observational studies have demonstrated feasibility and effectiveness of CRSP for TIA
patients. Tanne et al. (2008) found that a supervised exercise program that also involved
other components such as patient education and exercise prescription similar to CRSP
resulted in improvements in exercise capacity demonstrated by the improvement in the 6
minute walk test among patients that underwent exercise training after a minor ischemic
stroke (n=43, p = 0.002) (63). Additionally, Tang et al., (2010) reported that among
participants enrolled in an adapted CRSP program, VO2 peak improved significantly at the
end of the program compared to the baseline period (n=41, p = 0.046) (64). Prior et al.,
(2011) demonstrated that a 6-month duration CRSP program of moderately intense exercise
training was feasible, safe and effective. They found significant, favourable intake to exit
changes in mean aerobic capacity (p < 0.001), total cholesterol (p=0.008), waist
circumference (p <0.001), body mass index (BMI)(p=0.003), and body
weight(p=0.001)(n=80) (60). A similar study investigating the feasibility and effects of 6month CRSP for individuals after TIA found significant improvements in VO2 (p=0.001),
resting heart rate (p=0.03), BMI (p=0.03), a reduction in the proportion of people with
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obesity (p <0.001), and abdominal obesity (p = 0.001) among a retrospective cohort (n=39).
In a prospective cohort (n=14), there were significant improvements in pre to post CRSP in
VO2peak (p=0.01), oxygen uptake at the ventilatory anaerobic threshold (VAT) (p=0.04),but
surprisingly, a significant increase in SBP (p=0.01) (65). Additionally, there was a significant
improvement in the Center for Epidemiologic Studies Depression Scale (CES-D) during the
intervention period (p = 0.007).
In an observational study investigating psychological profile and outcomes after
comprehensive cardiac rehabilitation for TIA patients, the mean depression (p<0.001),
anxiety(p<0.001), mental (p<0.001) and physical health status (p=0.031), word-list
learning(p<0.001), memory, digit symbol coding (p=0.002), and oral-verbal fluency scores
(p=0.006) improved significantly between entry and exit (46). While these changes were not
independently associated with CRSP, they suggested that given greater statistical power,
increased treatment intensity and/or duration could produce psychological, health status or
neurocognitive improvements after TIA/MNDS (46).

2.8.2 Randomized Controlled Trials
A pilot randomized trial evaluating the benefit of the cardiac rehabilitation program for a
non-acute ischemic stroke population by Lennon et al (2008) also found that overall
cardiovascular fitness (V02) improved and rated perceived exertion decreased in the
intervention group compared to controls (p<0.001). Additionally, Hospital Anxiety and
Depression Scale (HADS) score improved significantly in the intervention group (p<0.001)
(66). In a more educationally and behaviorally focused randomized trial exploring enhanced
secondary prevention following minor stroke and transient attack, Gillham and colleagues
(2010) found that a greater number of individuals in the intervention group (n=25) moved
from the contemplation stage of behavior change to the action stage compared to controls
(n=25). Exercise frequency(p=0.007) and fruit and vegetable consumption (p=0.033) also
increased in the intervention group (67).
Faulkner et al (2013) explored the effects of early exercise engagement (within 2 weeks of
symptom onset) on vascular risk among patients with TIA and MNDS enrolled in an 8-week
health enhancing physical activity program. They found a significant baseline to postintervention decrease in SBP and total cholesterol (TC) for the intervention group (n=30) but
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not control (n=30) (16). A subsequent study by Faulkner and colleagues (2014) exploring the
long-term effect of exercise on vascular risk factors found that participants who took part in
the intervention had a significantly greater change in SBP between baseline and postintervention compared to control (p <0.05)along with improvements in aerobic fitness
maintained at the 12-month assessment (68). In a recent study by Faulkner et al (2015)
investigating the psychosocial effects of early exercise engagement post-TIA and MNDS,
they reported a significant difference between the experimental group and control for the
Short Form-36 Health Survey (SF-36) physical health component score (p<0.01) (n=55) but
there were no differences in participants anxiety or depression between treatment groups
(69).
Similarly, Boss et al, (2014) explored post-stroke care and exercise after TIA and minor
ischemic stroke at 6 and 12 months post-intervention and demonstrated that in the acute
phase, post stroke care similar to CRSP is safe and feasible (n=20) (17). Furthermore, in a
study by Kirk et al (2014), they found a statistically significant reduction in cardiovascular
disease risk score in the intervention group compared to the control group (p=0.042).
Additionally, subjective health status measured by the SF-36 domains of physical functioning
(p=0.012)and mental health (p=0.039) found a significant between group improvement in the
intervention group compared to the control (70). In a more recent study by Boss et al (2017)
exploring cardiorespiratory fitness (CRF) after TIA and minor stroke reporting baseline data
concluded that majority of individuals with a TIA or minor stroke had demonstrated poor
CRF. Greater age, female sex, a history of cardiac disease, other vascular disease, chronic
obstructive pulmonary disease (COPD), use of beta-blockers, hypertension, BMI and
smoking were associated with lower VO2 peak (71).
In a study by Ihle-Hansen et al. (2014), investigating the effect on anxiety and depression
from a multifactorial risk factor intervention program similar to CRSP after stroke and TIA,
one-year post-stroke 4.7% and 14.5% patients in intervention and the control group suffered
from depression respectively (n=174). The difference between the intervention control group
for changes in HADS was statistically significant (p=0.044). Additionally, 8.2% and 14.6%
of the patients in intervention and control group suffered from anxiety, and this difference
was not statistically significant post-intervention (55). The author’s conclusions suggested
that a multifactorial risk factor management program that involves education and vascular
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risk factor modification may result in a decreased prevalence of depression and in turn lower
the HADS score one-year post stroke which has also been observed in other studies.
The PREVENT (6) and CRAFTS (72) trials are currently investigating the short and longterm effects of a comprehensive program of secondary stroke prevention services which
would include exercise, education and counselling programs in modifying vascular risk
factors in TIA and MNDS patients within 90 days.

2.8.3 Systematic Reviews and Meta-Analyses
An early systematic review and meta-analyses (SR-MA) by MacKay Lyons et al, (2013)
investigating non-pharmacological interventions for preventing secondary vascular events
after stroke or TIA suggested that interventions that reduce risk factors after stroke should be
given priority in health care (36). At that time, not many randomized controlled trials had
evidence to support this. Several new studies of lifestyle interventions with or without an
exercise program have been published. In a recent systematic review and meta-analysis (SRMA) by D’Isabella and colleagues (2017) investigating the effect of exercise on
cardiovascular risk factors following stroke or transient ischemic attack (four studies)
suggested that there are significant beneficial effects of all interventions (involving exercise
alone or exercise with other interventions) with respect to SBP, fasting glucose, fasting
insulin, and HDL-C. For meta-analyses for studies only involving exercise interventions,
significant effects of SBP, fasting glucose and HDL-C remained (73). The authors suggested
that ongoing work should depict the differential effects of exercise of TIA versus stroke.
Importantly, they also recommended exploring “dose-response” relationships.
A similar SR-MA by Deijle and colleagues (2017) investigating lifestyle interventions to
prevent cardiovascular events with or without an exercise program after stroke and TIA had a
total of five trials (n=1800) that used a cardiovascular fitness intervention and five trials
(n=222) that use a combined intervention including another behavior change intervention.
The main findings from this SR-MA showed a significant 3.6 mmHg reduction in SBP in the
lifestyle interventions compared to usual care. Trials with a cardiorespiratory fitness program
or combined intervention also showed a significant reduction in SBP and interventions that
lasted longer than 4 months and used more than 3 behavior change techniques were more
successful in decreasing SBP (74). Another SR-MA by Heron et al, (2017) investigated
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lifestyle interventions initiated 90 days after TIA or minor stroke found no improvement in
resting or peak SBP. There was also no treatment effect for heart rate and the 6-minute walk
test (75).

2.9 Benefits of Exercise Training
Generally, physical activity has been well studied due to its well-known effects on
cardiovascular disease (CVD) risks and all-cause mortality and research supports exercise
training for primary and secondary prevention of CVD. Several studies have shown that
exercise training improves cardiovascular function. Formal cardiac rehabilitation and
exercise training programs result in: 1) improvement in exercise capacity; 2) improvement in
lipid profiles; 3) reduction in inflammation; 4) reduction in indicators of obesity; 5)
improvements in behavioral characteristics; 5) improvement in quality of life and
components; 6) Improvement in autonomic tone; and 7) improvement in blood rheology (76).
Furthermore, exercise also alters vascular remodeling and results in the upregulation of
antioxidant defense mechanisms in various tissues (24).
Inflammation plays a prominent role in the pathology of many cardiovascular diseases.
Atherosclerosis results from plaque build-up within arterial walls and is an inflammatory
disease that is caused by monocyte derived macrophages that collect in arterial plaques and
are activated to release cytokines that damage vascular tissue (24). Exercise training has been
found to prevent and treat many established atherosclerotic risk factors such as high blood
pressure, insulin resistance, glucose intolerance, elevated triglycerides, low HDL-C, and
obesity (77). One study investigating healthy young adults in a 12-week exercise program
found that high intensity aerobic training down-regulated cytokine release from monocytes
(78). Other studies have reported that exercise stimulates cardio-protective anti-inflammatory
effects that may have a dose-response relationship (24). Additionally, physical activity has
been found to reduce inflammatory markers such as C-reactive protein (CRP) in a doseresponse manner as well.
Vascular endothelium contains a monolayer of cells that lines the entire circulatory system
and is involved in vascular homeostasis (79,80). The endothelium regulates arterial dilation
and constriction by producing vasodilator and vasoconstrictor agents (80). An important
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component of functional vascular endothelium is the production of nitric oxide (NO) by
endothelia nitrous oxide synthase (eNOS). NO has anti-inflammatory, vasodilatory and
platelet inhibitory effects that have key roles in the upkeep of vascular homeostasis. Exercise
training has been found to be associated with the increase in vascular expression of eNOS in
animals and humans. It is believed that exercise training improves endothelial function
through the increased shear stress on artery walls mediated by increased blood flow during
exercise (80).
Furthermore, exercise is also involved in beneficial vascular remodeling (24,76,80),
specifically exercise training has a substantial impact on the morphology of numerous blood
vessels. Structural changes in blood vessels are followed by functional changes that lead to
improved blood flow (80). Exercise promotes angiogenesis, which is the formation of new
blood vessels and the process involves the migration, growth and differentiation of
endothelial cells. Moreover, exercise training promotes arteriogenesis, which is the increase
in the diameter of large arterial vessels. Arteriogenesis compensates for the loss of function
of occluded arteries (80). These adaptations can contribute to the significant cardiovascular
performance and benefits gained by physically active individuals (81).
It has been reported that cardiac rehabilitation exercise training has important effects on
psychological stress including levels of depression, anxiety, hostility, and total psychological
stress (76). The prevalence of anxiety has been reported to fall by 61% in younger patients
and 32% in older patients after formal cardiac rehabilitation exercise training. The authors
also reported a reduction greater than 50% in the prevalence of depression among coronary
heart disease (CHD) patients (82). These findings align with other research that suggests that
structured exercise can alleviate clinical symptoms of depression, anxiety, and improve
general wellbeing (83).

2.10 Gaps in the Literature
TIA and MNDS carry a short-term risk of stroke and other vascular events, and there remains
a critical window of opportunity to deliver an appropriate and effective secondary prevention
program. Current research suggests that programs like CRSP may be a more effective means
of reducing cardiovascular risk and improving quality of life than standard care. It has been
demonstrated that it is feasible and safe for TIA/MNDS patients to partake in CRSP.
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Exercise training has been proven to be effective in this patient population, but there remains
an area of inquiry of how much exercise produces the best outcomes. Additionally, cognitive
impairment, quality of life, depression and anxiety remain important issues in TIA/MNDS
patients, and research remains inconclusive in this subject area which further justifies work
investigating this patient population at high risk of such deficits.
There remain gaps in the literature demonstrating the effect of CRSP on TIA and MNDS
patients due to small studies that incompletely assessed all relevant risk factors. Further
research is required to support a mandate to include TIA/MNDS patients in a readily
available community-based lifestyle modification program such as CRSP. It has been
suggested in a recent SR-MA that future work should investigate the differential effects of
exercise post-TIA versus post-stroke as well as exploring dose-response relationships (73).
Another SR-MA on cognitive impairment in TIA patients suggested that future studies
should utilize long term cognitive assessments to identify whether the cognitive effects are
transient, stationary, or progress over time in this patient population (41). Hence, a
significant gap still remains in the literature. Therefore, further studies are needed to assess
cardiac rehabilitation exercise training in a dose response manner and replicate the effects of
CRSP strategies after TIA/MNDS, as the CRSP model of care might fill this gap (62).
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Chapter 3
3 Thesis Objectives and Hypotheses
The primary objective of this thesis was to quantify the relationship between exercise
attendance (number of scheduled facility-based exercise sessions attended) and exit
functional capacity (METS) among the exercise trained TIA/MNDS patients.
The primary hypothesis was that there is a relationship between the number of exercise
classes attended among exercise trained individuals enrolled in CRSP and improvement in
functional capacity.
The secondary objectives for this thesis were:
i)

to determine whether CRSP programming among exercise-trained TIA/MNDS
patients is associated with significant improvements in intake to exit measures of
exercise capacity, lipid profile (HDL-C, LDL-C, TC, TG, non-HDL cholesterol),
fasting blood glucose, blood pressure (resting SBP and DBP) body measurements
and composition (weight, waist circumference, BMI).

ii)

to determine whether CRSP programming among exercise trained TIA/MNDS
patients results in significant pre-post changes in the following psychometric
domains: quality of life, anxiety, depression, general cognitive impairment,
attention and working memory, pre-morbid intellectual functioning,
speed/executive/abstraction, oral-verbal fluency, verbal memory and learning.

The secondary hypotheses were that exercise trained patients would have significant
improvements in their intake to exit measurements of exercise capacity, lipid profile,
blood glucose, blood pressure, body measurements and composition. Furthermore, they
would have intake to exit improvements in the aforementioned psychometric domains.
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Chapter 4
4 Methods
This chapter describes the methodology used to the complete this study. Section 4.1 provides
a description of the data source. Section 4.2 outlines the study design and participants.
Section 4.3 details the inclusion and exclusion criteria. Section 4.4 describes Cardiac
Rehabilitation and Secondary Prevention procedures. Section 4.5 describes the measurements
(independent and dependent variables, demographic characteristics, and risk factors). Section
4.6 outlines the statistical analyses for the demographic statistics, objectives, exploratory
analyses and other statistical considerations and section 4.7 outlines the ethics approval.

4.1 Data Source
Data from the St. Joseph’s Health Care London – CRSP Program research unit was used. The
St. Joseph’s CRSP program is a six-month outpatient program. During the study period
(2004 to 2014) the CRSP program served on average 490 patients each year. The program
features include: medical evaluation, comprehensive patient care coordination, exercise
program, lifestyle education, psychological services and smoking cessation. The St. Joseph’s
CRSP program is partnered with the YMCA in London, and exercise prescribed by the CRSP
team is carried out at the downtown YMCA supervised by CRSP staff. Along with evidencebased practice and improving outcomes for patients, the program also has a research
component and participants have an opportunity to participate in various studies. The
research unit collaborates with other CRSP teams such as the Ottawa Heart Institute Cardiac
Rehabilitation program to facilitate collaborative research that improves care and outcomes
for patients.

4.2 Participants and Study Design
This present study is a retrospective database review of the London CRSP clinical database.
This data source allowed us to examine participants utilization of CRSP in routine clinical
care and allowed us to investigate longer observation periods within specific subpopulations.
Additionally, a pre and post study design was used, which examines whether participants in
an intervention improve or regress during the course of the intervention. For this study
design, participants are their own control. Without reference to another control group we
cannot make causal inferences with this study design.
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From January 4th, 2004 to 2014, a total of 271 TIA/MNDS patients were study eligible for
three studies conducted by London and Ottawa cardiac rehabilitation programs. Patients who
had presented in the Emergency Department with a TIA were referred to a Stroke Prevention
Clinic (SPC) and were generally assessed as outpatients within 48 hours to one week of the
event. A SPC is an outpatient clinic for people who are at risk of having a TIA or stroke.
They also provide care for those who have already experienced a stroke. The SPC provides
investigative testing, medical evaluation, medical counselling, and attempts to provide homebased risk factor management by providing patients with information about self-referral to
risk reduction programs in the community. Case management within these services is limited
and typically TIA clinic patients do not have access to CRSP. Both London and Ottawa have
SPCs and CRSP programs and participants for these studies were recruited from a SPC.
From these participants, we used the 115 facility-based exercise-trained individuals to
conduct the study. Figure 1 illustrates the participant selection flow chart.
The first study was an observational study investigating the feasibility and risk factors of
comprehensive CRSP after transient ischemic attack or mild stroke at the St. Joseph’s CRSP
program (60). The second study was a pilot randomized single blind controlled trial
investigating CRSP among survivors of transient ischemic attack, also at the London Cardiac
Rehabilitation program (84). Lastly, the third study was a multi-site randomized controlled
trial investigating CRSP programming as secondary prevention for survivors of TIAs
(unpublished). This study was conducted in both London and Ottawa.
For the first observational study, 100 participants receiving usual care per the SPC were
enrolled in comprehensive cardiac rehabilitation for about 7 months at the St Joseph’s CRSP
program. This was delivered in addition to usual care, which followed the Heart and Stroke
Foundation of Ontario/Coordinated Strategy Guidelines plus standard secondary prevention
advise to the patient and family doctor to adhere to risk factor targets, including exercise
(14). For the second randomized controlled trial, of the 39 individuals eligible, 19 subjects
were randomized to SPC usual care (UC) and 20 subjects we randomized to UC and
comprehensive 6-month cardiac rehabilitation. In the third multi-center trial, of the 132
subjects, 72 were randomized to UC and cardiac rehabilitation and 60 were randomized to
UC.
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4.3 Inclusion and Exclusion Criteria
The inclusion and exclusion criteria were similar across all three studies. The first
observational study, second pilot randomized controlled trial and third multi-center
randomized controlled trial inclusion criteria were as follows:
i) Patients were eligible if they were at least 20 years old; had sustained a
documented TIA/MNDS within the previous 12 months; had at least 1 of the
following risk factors: hypertension, diabetes mellitus, dyslipidemia, ischemic
heart disease (i.e., self-report of angina pectoris, myocardial infarction, or
coronary angioplasty within the previous year) acknowledged cigarette smoking
within the previous year and spoke and understood English.
ii) 1) Aged 20 years or more; 2) Documented TIA and/or MNDS within the previous
three months; 3) Has at least one of the following vascular risk factors:
hypertension, diabetes mellitus, dyslipidemia, ischemic heart disease (angina
pectoris and/or myocardial infarction within the last one year), cigarette smoking;
4) Has a modified Rankin Scale of < 3; 5) Has a mini-mental status examination
score >20; 6) No evidence of intracranial hemorrhage on CT scan or magnetic
resonance imaging study; 7) No anticipated or recent (< 30 days) carotid
endarterectomy, angioplasty and/or stenting; 8) Speaks and understands English;
9) Able to communicate verbally; 10) Able and willing to provide written,
informed consent.
iii) 1) Aged 20 years or more, 2) Documented TIA and/or MNDS within the previous
3 months, 3) Speaks and understands English, 4) Able to communicate verbally
and willing to provide written, informed consent, 5) At least one of the following
vascular risk factors: a) hypertension b) Diabetes mellitus by self-report or use of
oral hypoglycemic agents or insulin, c) Dyslipidemia , d) Ischemic heart disease
(self-report of angina pectoris and/or myocardial infarction and/or coronary
angioplasty within the previous one year), e) Cigarette smoking within the
previous year.
The exclusion criteria for the first observational study, second pilot randomized controlled
trial and third multi-site randomized controlled trial inclusion criteria were as follows:
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i) Patients were ineligible if they had evidence of intracranial hemorrhage on a CT
or MRI study; anticipated or had undergone recent (<30 days) carotid
endarterectomy or percutaneous coronary intervention; showed evidence of
disabling stroke or dementia as measured by modified Rankin Scale score of ≥3 or
a Mini-Mental Status Examination (MMSE) score ≤20; had previously
participated in CRSP; were unable to perform CRSP exercise training; or were
participating in another clinical study that could interfere with the intervention or
outcomes of the current study.
ii) 1) Reside > 1-hour travel time from London, 2) Prior participation in CRSP, 3)
Inability to perform expected exercise of CRSP program.
iii) 1) Evidence of intracranial hemorrhage on CT scan or magnetic resonance
imaging study, 2) Anticipated or recent (< 30 days) carotid endarterectomy,
angioplasty and/or stenting, 3) Evidence of disabling stroke or dementia as
measured by modified Rankin Scale of >= 3 (103;104) or a MMSE =< 20 (94), 4)
Reside > 1 hour travel time from London or Ottawa 5) Prior participation in
CRSP, 6) Inability to perform expected exercise training of CRSP program, 7)
Evidence of a cardioembolic source for TIA/stroke such as atrial fibrillation,
valvular disease, septal defect or left ventricular wall motion abnormality, 8)
Participating in another clinical study which could interfere with the intervention,
or outcomes of the current study.

4.4 Cardiac Rehabilitation and Secondary Prevention
Intervention
CRSP at both London and Ottawa comprises 1) an initial medical assessment by a nurse case
manager and a CRSP physician to determine CRSP strategies 2) an entry exercise stress test
3) nutrition counselling, kinesiology, and psychological (where needed) assessment and
intervention to achieve risk factor targets 4) individualized and prescribed twice per week
supervised exercise training and twice per week supplementary home-based training 5) exit
assessment at six months.
Participants were required to attend a two-hour orientation/ information session to familiarize
themselves with the program. Orientation was in a group setting and the subjects received
risk factor and service education, screening with the HADS and SF12, a requisition for blood
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work, and advice to quit smoking. The participants where then advised to return for an intake
appointment where they were approached to consent to the use of their program data for
various research purposes. Subjects then attended an intake clinic for medical and risk factor
assessment by the nurse case manager and physician, with anthropometric measurements, a
45-to-60-minute neuropsychological battery and additional support to join the CRSP
smoking cessation program. Furthermore, subjects underwent standardized, physician
supervised, exercise stress testing using a “ramp” protocol which consists of an initial twominute stage at two mph and 0% grade, followed by one-minute stages at three mph
continually, grade increasing by 1.7% each minute. All participants were enrolled in a CRSP
exercise program administered by a kinesiologist. The program offers standard on-site, twice
weekly, 50-session option with additional home-based exercise training at least twice
weekly; or subjects had the choice to do a full home-based training which comprised at least
4 days recommended exercise weekly and monthly telephone or onsite check-in.
Nutrition counselling by a registered dietician was delivered individually or in a group
setting highlighting the Mediterranean diet. If a subject scored a value greater or equal to 8
on the HADS anxiety (HADS-A) or depression (HADS-D) or HADS-A + HADS-D score
greater or equal to 14 (85), they were offered referral to a clinical psychologist. Referral to a
clinical psychologist was also made based on clinician judgement or patient request. Case
management by the nurse continued throughout CRSP programming with a three month-visit
or phone call to the subject. Lastly, an exit clinic with the nurse case manager, physician, and
psychometrist was made approximately six months after intake and the same intake
measurements were taken.
In 2014 the Cardiac Care Network published standards for the provision of cardiovascular
rehabilitation in Ontario. These standards aimed to reduce variation in care. Prior to those
standards, there were published clinical guidelines by the Canadian Association of
Cardiovascular Prevention and Rehabilitation but there were no published standards for
delivery of CRSP in Canada. For our study period (2004-2014), it was assumed that the
CRSP standard of care was similar across all three studies. Specifically, the first two studies
were conducted by the London CRSP program which constituted the majority of the study
sample, and the study protocols in terms of service provision were similar across all three
studies. Additionally, due to the nature of the study design (retrospective database review),
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we can only rely on study protocols. It is possible that following the publication of new
standards, CRSP programs may have altered their clinical practice, but that would not affect
our study cohort.

4.5 Measurements
Demographic characteristics were collected at intake. These measures included age, sex,
education, occupation, occupational status and ethnicity. Number of days in CR was
calculated using CR intake assessment date and CR exit assessment date. Risk factor data
including dyslipidemia, hypertension, sedentary lifestyle, family history, post-menopausal
syndrome (PMS), diabetes, and tobacco use were also collected at intake. Sedentary lifestyle
was defined as failure to meet the recommendations of the Canadian Physical Activity
Guidelines of 150 minutes of moderate-vigorous-intensity aerobic physical activity per week
in bouts of 10 minutes or more (86,87). Family history of CVD, and cerebrovascular diseases
was asked as a “yes or no” question with added details.

4.5.1 Independent and Dependent Variables
The primary independent variable was the number of scheduled attended exercise sessions in
YMCA-based exercise programming. Additionally, pre and post measurements of exercise
capacity, blood pressure, lipid profile, blood glucose, body measurements and composition,
Duke Treadmill Score, quality of life, anxiety, depression, general cognitive impairment,
attention and working memory, verbal learning and memory, pre-morbid intellectual
functioning, and speed/executive/abstraction were also measured.
Exercise training sessions were scheduled by the CRSP program and attendance records
where kept for facility-based exercise sessions. Prescribed home-exercise was monitored
through check-in phone calls to the participants. Exercise capacity was measured using
METS using standardized peak exercise treadmill testing using validated equations that use
speed in miles per hour and grade of the treadmill.
METS = [3.5+(2.7× speed) + 48.2 (treadmill speed in mph) × (grade)] ÷ 3.5;
where grade = fractional grade.
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Resting systolic and diastolic blood pressure was measured by the clinic nurse. Lipid profile
was obtained from blood work. Specifically, TC, HDL-C, and TG, was measured through
blood work. Non-HDL-C was calculated (TC÷HDL-C), and LDL-C was calculated using the
Friedewald equation (88).
LDL-C = TC – HDL-C – [(TG) ÷2.2]
Fasting blood glucose was also measured through blood work. Height, weight, and waist
circumference were measured by the clinic nurse, and BMI was calculated from height and
weight measurements. Furthermore, the Duke Treadmill Score, a weighted index combining
treadmill exercise time (in “standard Bruce protocol” minutes, maximum net ST segment
deviation (depression or elevation), and exercise-induced angina) was calculated. The Duke
Treadmill Score (DTS) is a prognostic index value to predict the presence of CAD, has
validated mortality risk categories on those with CAD and/or suspected of having CAD (89),
and may be calculated using the following equation (90):
DTS = Exercise Time – (5 x Max ST (mm)) – (4 x treadmill angina index)
Ex Time:

Bruce protocol minutes (91)
= [(METS x 3.5) – 8.545] ÷2.282

Max ST:

Maximum net ST deviation

Angina Index:

0 = No angina during exercise
1 = Non-limiting angina
2 = Exercise limited angina

The typical range observed for DTS is from -25 (highest risk) to +16 (lowest risk). A DTS
greater or equal to +5 indicates low risk, a score between -10 to +4 indicates moderate risk,
and high risk is a value less than -10. Additionally, the low risk category reflects a four-year
survival rate of 99%, moderate risk category reflects a four year survival rate of 95%, while
the high risk category reflects a four year survival rate of 79% (89). Five-year mortality rates
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have also been reported as 3%, 10% and 35% for low-, moderate-, high-risk DTS categories
(92).
Quality of life and health status were measured by the SF-12. The SF-12 Health Survey is a
standardized questionnaire which includes 12 items selected from the Short Form 36 – item
health survey (93). The SF-12 includes the following dimensions: physical functioning, rolelimitations – physical, bodily pain, general health vitality, social functioning, role limitations
– emotional, and mental health. It is used to assess patients’ health-related quality of life and
produces two summary scores – physical and mental health summaries denoted PCS and
MCS that range from 0 to 100, (US population mean = 50, SD = 10) (94) where a score of
zero denotes the lowest level of health measured and a score of 100 indicates the highest
level of health (95). HADS was used to assess depression and anxiety (96). HADS is a selfrating patient reported measure with 14 items divided into two equal subscales (HADS-A)
and depression (HADS-D) where respondents self-report occurrence of symptoms related to
anxiety or depression over the past 7 days. The HADS-A has questions on tension, worry
fear, panic and difficulties relating. The HADS-D has questions predominantly measuring
anhedonia (97). The responses are rated on a 4-point Likert scale and range from 0 to 3 with
the higher score indicating greater severity. The 14 items are summed to a total score of 0 to
42 or for each subscale 0 to 21 (97). The HADS concentrates on non-physical symptoms to
avoid confounding of psychological and medical symptoms, so that it can be used to screen
individuals who are physically ill (98).
General cognitive impairment was measured using MMSE – a popular measure to screen for
cognitive impairment particularly in the elderly, track changes that occur with time, and
assess the effect of therapeutic agents on cognitive functioning (99). The MMSE produces a
score with the total number of correct answers – the maximum score is 30 points for adults.
There are different methods to assess the MMSE score. There is a single cut-off that can be
used – a score <24 is considered abnormal. A range method can also be used – a score < 21
means increased odds of dementia, and a score >25 means decreased odds of dementia.
Degree of cognitive impairment can be assessed with the following cut-offs: 0-10 (severe),
10-20 (moderate), 20-25 (mild) (100). The North American Adult Reading Test (NAART)
was used to measure pre-morbid intellectual functioning (99). The NAART is a reading test
that requires participants to read out loud 61 irregularly spelled words. The responses are
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individually scored as correct or incorrect based on the pronunciation, and the score can be
used to estimate pre-morbid IQ (101).
Attention, working memory and mental flexibility were measured using the Digit Span
Forwards and Backwards from the Wechsler Adult Intelligence Scale - Revised (WAIS-R).
The WAIS-R is used to provide a measure of general functioning in older adolescents and
adults and contains 11 subtests (99,102). Performance of this subset is reported as a single
score which is comprised of the additive combination of the Digits Forward and Digits
Backward, this score is then converted into a scaled score and age-scaled score (103). The
Similarities subtest of the WAIS-R was used to assess judgement and analogical
reasoning/abstraction. For the Similarities subset, participants are given two words or
concepts and have to describe how they are similar (99) and raw, scaled, and age-scaled
scores are derived. Furthermore, the Digit Symbol subset of the WAIS-R was also used to
measure psychomotor speed. The Digit Symbol requires the subject, on the basis of a
numeric-symbol coding key, to produce a sequence of symbols correctly coded within 90
seconds, and the higher the score the better the subject’s performance. Raw, scaled, and agescaled values are also produced (99). WAIS-R instead of the recent WAIS-III was used to
allow for comparability across the three studies.
Attention, speed, and mental flexibility was also measured using the Trail Making Test
(TMT). The TMT involves the participant drawing lines sequentially to connect 25 encircled
numbers randomly arranged on a page in proper order (Part A) and then connecting 25
encircled numbers and letters in alternating order (Part B) (99). The score is expressed as the
amount of time it takes the participant to complete the task for each part (104) therefore,
higher scores show greater impairment (99). The Rey Auditory Verbal Learning Test
(RAVLT) measures verbal learning and memory. The RALVT evaluates immediate memory
span, new learning, vulnerability to interference and recognition memory. The RALVT
involves five free‐recall trials, recall after interference trial, and a recognition trial (99). The
Clock Drawing Test (CDT) was used to assess visual-constructive skills. The CDT also taps
into a series of cognitive domains such as verbal understanding, memory, spatial knowledge,
abstract thinking, planning, and concentration and as previously mentioned visualconstructional functioning (99,105,106). A score out of 4 on the CDT and time measured in
seconds was collected. For the CDT a score less than or equal to 2 indicates ‘defined
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impairment’ (105). Furthermore, oral verbal fluency was measured by the Controlled Oral
World Association Test (COWAT) – a widely used test of executive dysfunction (107). The
COWAT requires subjects to name as many words beginning with a single letter as they can
in one minute, and the most commonly used form of this test uses the letters F, A, and S
(99,108).

4.5.2 Demographic Characteristics
The demographic variables collected included: age (date of birth); sex (male, female); ethnic
group (Aboriginal, Arab/West Asian, Black, Chinese, Filipino, Japanese, Korean, Latin
American, South Asian, South East Asian, White/Caucasian); education (no formal
education, elementary: some, elementary: completed, high school: some, high school:
completed, trade school: some, trade school: completed, university/college: some,
university/college: completed, post graduate: completed); occupational status (full-time, parttime, unemployed, retired, not/never employed outside the home, short-term disability, longterm disability, employed: permanent restrictions, employed: modified duties); occupation
(self-employed professionals, semiskilled manual, employed professionals, foreman, skilled
clerical-sale-services, farm works, high level managers, skilled blue-collar workers,
semiskilled clerical-sales-services, unskilled manual, middle-level managers, supervisors,
homemaker); living situation (alone, with spouse/partner, with friends, with family, with
others); New York Heart Association Functional Classification (Class I: no limitation in
normal physical activity, Class II: mild symptoms only in normal activity, Class III: marked
symptoms during daily activities, asymptomatic only at rest, Class IV: severe limitation,
symptoms even at rest); and Canadian Cardiovascular Society (CCS) grading of angina
pectoris (Class 0: asymptomatic angina, Class I: angina only with strenuous exertion, Class
II: angina with moderate exertion, Class III: angina with mild exertion, Class IV: angina at
rest).
For the purposes of this study, three of these variables were further categorized. Education
was categorized into “Less than High School” (including no formal education, elementary:
some, elementary: completed, high school: some), “High School” (including high school:
completed), “Some Post-Secondary” (including trade school: some, university/college:
some), and “Graduated College/University” (including trade school: completed,
university/college: completed, post graduate: completed). Occupational status was
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categorized into “Full-time” (including, full-time, employed permanent restriction, employed
modified status), “Part-time” (including part-time), “Unemployed/Disability” (including
unemployed, not/never employed outside the home, short-term and long-term disability),
“Retired”, and “Not obtained/missing”. BMI was further categorized to “BMI > 25” to
indicate individuals who are classified as overweight (109). Due to the sample being
predominantly White/Caucasian, ethnic group was further categorized into
“White/Caucasian” and “Other” (including Aboriginal, Arab/West Asian, Black, Chinese,
Filipino, Japanese, Korean, Latin American, South Asian, South East Asian).

4.5.3 Risk Factors
The risk factor data collected included: sedentary lifestyle (yes, no); dyslipidemia (yes, no);
hypertension (yes, no); family cardiovascular disease history (yes, no); post-menopausal
syndrome (yes, no); diabetes (yes, no); diabetes type (Type 1, Type 2); smoking history
(current smoker, former smoker, non-smoker).

4.6 Statistical Analyses
4.6.1 Data Processing
This study included three different study samples and involved some data processing before
conducting the statistical analyses. Zhu et al. (2013) guidelines (110) were used as reference
during this process. The data processing began with getting to know the studies (research
questions, recruitment criteria, and data collection methods). The second step was to check
whether common variables were measured in the same manner and checking if the variable
coding was similar across studies. The third step was ensuring the data entry across the
studies was accurate and identified any missing variables. Once these steps were complete
and the datasets were combined, data cleaning was done which involved looking for
incorrectly coded variables, correcting coded variables, looking for missing data, checking
for any outliers, and correcting the identified data errors.

4.6.2 Demographic Statistics
Two approaches were used to describe baseline characteristics of TIA/MNDS patients
enrolled in the CRSP program. Continuous variables (i.e. age, BMI) were summarized using
means and standard deviations. Categorical variables (sex, ethnic group, education,
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employment status, living situation, cardiovascular risk factors, and history of CAD, TIA,
and stroke) were summarized using frequencies (n/%).

4.6.3 Confounding Variables
A confounding variable is a variable that influences both the dependent variable and
independent variable, causing a spurious association. There are many factors that can
confound the association between exercise attendance and functional capacity. Specifically,
factors associated with physical inactivity include but are not limited to: older age, female
gender, prior physical activity habits, and fitness level (111). Physical activity has been found
to be lower in older females, and age related physical deficits can influence adherence as well
(112). Additionally, baseline functional capacity, a sedentary lifestyle, can influence
adherence and exit functional capacity. For this study sex, age, sedentary lifestyle, and intake
functional capacity were controlled for in the regression model.

4.6.3 Analyses for Objectives
Analytic techniques appropriate for pre-post study designs were used where necessary. The
statistical analysis corresponding to each study objective is listed as follows:
Objective 1: Quantify the relationship between exercise adherence and functional capacity
among exercise trained TIA/MNDS patients.
A multiple linear regression analyses was used to test whether there was an association
between exercise adherence (number of scheduled exercise sessions attended) and functional
capacity. The regression model included number of scheduled exercise sessions attended as
the predictor variable and exit measure of METS as the dependent variable while controlling
for intake measure of METS, and confounding variables (age, sex, and lifestyle).
Objective 2a: Determine whether CRSP programming among exercise-trained TIA/MNDS
patients is associated with intake to exit improvements in exercise capacity, lipid profile,
blood pressure, body measurements and composition.
Objective 2b: Determine whether CRSP programming among exercise trained TIA/MNDS
patients results in intake to exit changes in the following psychometric domains (quality of
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life, anxiety, depression, general cognitive impairment, attention and working memory, premorbid intellectual functioning, speed/executive/abstraction).
To compare the mean intake and exit values for the continuous variables, paired t-tests were
used.
All statistical tests were two-tailed with an alpha level of 0.05. To control for type one errors
a Bonferroni correction (113) (α=0.05÷ number comparisons) within each domain of
dependent variables was employed. For key CRSP outcomes there were 5 domains:
functional capacity, lipid profile, blood glucose, blood pressure and body composition.
Functional capacity measured in METS and blood sugar has an alpha level of 0.05. Lipid
profile (TC, LDL-C, HDL-C, non-HDL-C, TG) had an alpha level of 0.01, blood pressure
(SBP, DBP) had an alpha level of 0.03, and body composition (WC, BMI, weight) had an
alpha level of 0.02. Additionally, adjustments were made for the seven psychometric
domains (depression and anxiety; quality of life; general cognitive impairment; attention and
working memory; verbal learning and memory; speed, executive, abstraction; and pre-morbid
intellectual functioning). Depression and anxiety (HADS-T, HADS-A, HADS-D) had an
alpha level of 0.02, and quality of life (SF12-PCS, SF12-MCS) had an alpha level of 0.03.
General cognitive impairment and pre-morbid intellectual functioning had an alpha level of
0.05. Attention and working memory (Digits-Forward, Digits-Backward, Trails A) and
verbal learning and memory (RAVLT-sum, A6, A7) had an alpha level of 0.02 while speed,
executive and abstraction (Digit Symbol, Trails B, CDT, FAS-OVF, Similarities) had an
alpha level of 0.01. Appendix B illustrates these calculations.

4.6.4 Exploratory Data Analysis
For exploratory purposes only, the relationship between exercise attendance (number of
scheduled facility-based exercise sessions attended) and exit DTS risk category (low risk,
moderate risk, and high risk) was investigated. An ordinal logistic regression (114) was used
to predict DTS risk category given exercise attendance. A McNemar’s chi-square test was
used to explore whether there was an association between intake high-risk DTS category and
exit high-risk DTS category.
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4.6.5 Missing Data
Missing data is of concern with the key analytical variables collected for the study as it can
impact validity and may result in bias. Due to the pre-test, post-test study design, any pairs of
values where one of the pairs is missing was excluded. Specifically, cases were excluded
analysis by analysis, which maximizes all of the data available. Pairwise deletion assumes
that missing data are missing completely at random.

4.6.6 Assessment of Potential Selection Bias
Patients that were excluded in the study sample due to either being in the control group from
the RCTs, enrolling in the home-based exercise program, or not completing the program
were excluded from the analyses. This information was required to determine their change in
functional capacity for the primary objective. To determine the generalizability of the study
results, the demographic characteristics were compared between subjects that completed
CRSP and subjects that did not complete CRSP. This was conducted to determine whether a
systematic difference in the patient characteristics existed between those that completed the
program and were selected for the study compared to those that did not complete the
program.

4.6.7 Assessment of Potential Non-Response Bias
Non-response bias is defined as a systematic error due to differences in characteristics
between respondents and non-respondents (115). Non-response of key variables can result in
statistical analyses that are biased and the variability in the data will be incorrectly estimated.
The literature suggests that missing data of 10% or more would be of concern (116). All
variables with at least 10% missingness were further assessed to determine the extent of
response bias present. A comparison of demographic characteristics between subjects that
had information on a variable versus subjects that did not have information on a variable was
made to determine if the characteristics between the two groups systematically differed. If
differences were found, that would suggest that the observed results would be less
generalizable compared to if the data was missing at random.

4.6.8 Software
All statistical analyses were completed using IBM SPSS Statistics 21.0.
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4.9 Ethics Approval
The studies used in this project were approved by the University of Western Ontario’s
Research Ethics Board.
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Figure 1. Participant Selection Flowchart
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Chapter 5
5 Results
This chapter reports the study results. Section 5.1 reports on the process, while Section 5.2,
and 5.3 reports demographic characteristics, and risk factors at baseline. Section 5.4 reports
the baseline health status measures while section 5.5, 5.6, and 5.7 reports the results for
objective 1, 2a, and 2b respectively. Section 5.8 reports findings from the additional
exploratory analyses, and Section 5.9 discusses missingness. Additionally, 5.10, 5.11, and
5.12 reports the assessment of selection bias, assessment of non-response bias, and adverse
events respectively.

5.1 Process
Of the 271 TIA/MNDS study eligible participants from the three studies conducted by
London and Ottawa CRSP programs, 115 participants met the selection criteria, and the
remaining participants where either in the control group for the RCTs or enrolled in the
home-based exercise option. Of the 115 participants in this study, 98 (85%) were recruited
from the London CRSP program, and 17 (15%) were recruited from the Ottawa CRSP
program. Sixty-two participants (54%) were from the first observational study, 13 (11.3 %)
from the first randomized controlled trial (RCT) and 40 (35%) participants from the second
RCT. Table 1 outlines these characteristics along with other baseline characteristics. The
mean interval for CCR intake assessment to exit assessment was 236 days (34 weeks; n =94)
and ranging from 140 to 588 days. All subjects selected enrolled in the facility-based
exercise option. On average, participants attended 33 (SD = 12.0; 1 – 60, n=109) exercise
sessions or 66% of the 50 typically prescribed sessions. Table 4 provides an exercise
attendance summary and Appendix A provides the attendance breakdown.

5.2 Baseline Characteristics
A description of the study sample’s baseline characteristics is available in Table 1. Of the
115 participants selected, 65 (57%) participants were male, and 50 (43%) were female, with
an average age of 66 (10.2) years. The majority of the sample was White/Caucasian (96%)
with the remaining individuals being Asian, Black, Aboriginal, and Latin American. Over
50% of participants had high school as their highest level of education (27% less than high
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school, 26% graduated high school), while 14% had some post-secondary education, and
29% graduated university/college. Forty-five participants were either employed full-time
(34%) or part-time (5%), while 39% were retired and 5% were on disability/unemployed.
Twenty-six (23%) participants reported living alone, while 67 (58%) and 3 (3%) participants
reported living with a partner/spouse and with others respectively. Furthermore, 81 (70%)
participants were classified as Class I (no limitation in normal physical activity) for the
NYHA functional classification while 13 (11%) participants were classified as Class II (mild
symptoms only in normal activity) and 5 (4%) participants were classified as Class III
(marked symptoms during daily activities). For the CCS Grading System of Angina Pectoris,
94 (82%) participants were classified as Class 0 (asymptomatic angina), 4 (4%) participants
were classified as Class I (angina only with strenuous exertion), and one participant was
classified as Class II (angina with moderate exertion).

5.3 Risk Factors at Baseline
Of the 115 participants, 67 (58%) participants reported having a sedentary lifestyle, while
91(79%) and 89 (77%) had dyslipidemia and hypertension respectively. Additionally, 48
(42%) of participants had a family history of CVD, and 30 (26%) had diabetes (2 participants
with type 1 diabetes and 28 with type 2 diabetes). Forty-two (37%) participants were nonsmokers while 17 (15%) and 55 (48%) were current smokers and former smokers
respectively. The mean BMI for the sample was 29.8 with 93 participants (81%) classified as
overweight (BMI >25). Table 2 outlines risk factors at baseline.

5.4 Baseline Health Status Measures
Table 3 outlines the baseline health status measures. For the quality of life measures –
measured by the SF-12, the mean physical composite score was 43.6 (9.9) ranging from 20.5
– 60.7, and the average mental composite score was 51.4 (8.9), ranging from 24.6 - 64.0.
Eighteen (16%) of participants met the cut-off of having HADS depression score greater than
or equal to 8, while 29 (25%) participants met the cut-off of having HADS anxiety score
greater than or equal to 8. The average HADS total score was 9.3 (6.3), with 23 (20%)
participants meeting the cut-off of having a HADS total greater than or equal to 14.
Furthermore, the average DTS score was -5.8 (7.3). Specifically, 9 (8%) participants were in
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the “low risk” category for the DTS while 65 (57%) and 24 (21%) were in the “moderate
risk” and “high risk” categories respectively.

5.5 Objective 1
A multiple linear regression was used to understand the association between the number of
exercise sessions attended in CRSP and functional capacity (METS) at exit while controlling
for intake METS, sex, age, and sedentary lifestyle. The regression model statistically
significantly predicted exit functional capacity, F (5,97) = 56.7, p<0.001, accounting for
74.5% of the explained variation in exit METS with an adjusted R2 = 0.73, a large effect size
according to Cohen (1988) (117). The regression model predicting exit METs predicted an
increase of 0.6 METs for every 10 exercise classes attended ( = 0.6, 95% CI 0.3, 0.9, p
<0.001). All variables except for sex (p=0.30) were statistically significant in the model.
Regression coefficients, standard errors, and 95% CI for the crude and adjusted models can
be found in Table 5. Other models from the model building process can be found in
Appendix C.

5.6 Objective 2a
There were significant intake-to-exit improvements in functional capacity, total cholesterol,
non-HDL-C, triglycerides, diastolic blood pressure, waist circumference, BMI and weight.
For functional capacity, there was a 28% improvement in functional capacity from intake to
exit [intake METS 6.5 (2.7), exit METS 8.5 (3.0), p < 0.001]. The proportion of subjects
meeting the functional target of ≥ 7 METS from intake to exit improved from 37% to 62%.
Figure 2 outlines the intake and exit distribution of METS. For total cholesterol, there was a
6% decrease from intake to exit [intake 4.3(1.2) mmol/L, exit 4.0 (1.1) mmol/L, p=0.006]
while non-HDL-C decreased by 10% [intake 3.4 (1.1), exit 3.03 (1.0), p <0.001]. For
triglycerides, there was a 19% decrease from intake to exit [intake 1.6 (1.3) mmol/L, exit 1.3
(0.7) mmol/L, p=0.004]. Additionally, DBP decreased by 4% from intake to exit [intake 79.3
(8.8) mmHg, exit 76.5 (8.1) mmHg, p = 0.004]. There was a 2% decrease in waist
circumference [intake 101.3 (12.6) cm, exit 96.9 (11.8) cm, p <0.001], and a 2% decrease in
BMI [intake 29.7 (4.9) kg/m2, exit 29.1 (4.7) kg/m2, p <0.001]. Lastly, there was a 2%
decrease in weight from intake to exit as well [intake 83.9 (14.3) kg, exit 82.2 (14.4) kg, p
<0.001].

40
There were no statistically significant intake to exit improvements in LDL-C, HDL-C, fasting
blood glucose, and SBP. Although LDC-C, and HDL-C did not statistically significantly
change from intake to exit, there was an 9% decrease in LDL-C from intake to exit [intake
2.2 (1.0) mmol/L, exit 2.0 (0.9) mmol/L, p=0.014] and there was a 5% increase from intake
to exit for HDL-C [intake 1.3 (0.4) mmol/L, exit 1.4 (0.4) mmol/L, p =0.48]. There was not a
statistically significant change in fasting blood glucose from intake to exit [intake 5.9 (1.5)
mmol/L, exit 5.9 (1.4) mmol/L, p =0.909]. Lastly and although not statistically significant,
there was a slight 2% decrease in SBP [intake 133.1 (17.8) mm Hg, exit 130.9 (15.5) mm Hg,
p =0.233]. Table 6 outlines these results.

5.7 Objective 2b
There were statistically significant intake to exit improvements in the HADS-D, HADS-A,
HADS-T, SF-12 PCS, Digit Symbol, Rey Auditory Verbal Learning Test, and FAS Oral
Verbal Fluency. Furthermore, intake to exit changes in SF-12 MCS, MMSE, NAART, Digit
Forward and Backwards, Similarities, Trails-A, Trails-B, and CDT were not found to have
statistically significant intake to exit changes. Table 7 outlines these findings further.
HADS
For the HADS depression score, the average score had a statistically significant change from
intake to exit. There was an average 1.2 unit change from intake and exit points [intake
3.5(3.0), exit 2.3 (2.8), p < 0.001]. Additionally, there was a 1.1 unit change in the HADS
anxiety points between intake and exit which was also statistically significant [intake 5.3
(3.6), exit 4.2 (3.4), p < 0.001]. Consequently, there was a statistically significant intake to
exit change in the HADS-T score [intake 8.9 (5.7), exit 6.6 (5.5), p < 0.001].
SF12
The SF12 mental composite score did not have a statistically significant intake to exit
difference, but there was a 2 unit increase in the average score [intake 51.4 (9.2), exit (11.4),
p < 0.001], but the SF12 physical composite score had a statistically significant 3.5 unit
increase from intake to exit [intake 46.6 (10.0), exit 47.1 (10.3), p = 0.001].
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General Cognitive Impairment
General cognitive impairment was measured by the MMSE. At intake, three subjects had a
score less than 24 which is considered abnormal, and at exit 4 participants had a score less
than 24. The mean change in MMSE points from intake to exit was not statistically
significant [intake 28.2 (1.6), exit 28.2 (1.9), p=0.669].
Attention and Working Memory
The Digit Span (forwards and backwards) and Trails-A assessed participants attention,
working memory, and mental flexibility. There were no statistically significant intake to exit
improvements in these psychometric domains. For the Digit Span Forward, there was a 0.2
unit increase in raw points [intake 7.9 (2.4), exit 8.2 (2.4), p=0.246], and there was a 0.2 unit
decrease in raw points [intake 6.5 (2.4), exit 6.3 (2.6), p=0.303] for the Digit Span
backwards. Lastly, there was an 8% decrease in seconds used to complete the task between
intake and exit for the Trails-A [intake 39.3 s (27.0), exit 36.2 s (16.2), p=0.164].
Verbal Learning and Memory
Verbal learning and memory were measured by the RAVLT, and specifically evaluates
immediate memory span, new learning, vulnerability to interference, delayed recall and
recognition memory. For the RAVLT total which involves the total for the five free recall
trials there was a 10% intake to exit improvement in the number of recalled words [intake
42.0 (8.6), exit 46.2 (10.3), p<0.001]. For the recall after interference trial denoted “A6”,
there was also a 10% increase in the number of words recalled from intake to exit [intake 8.2
(3.0), exit 9.0 (3.4), p=0.001]. Lastly, for the recognition trial denoted “A7”, there was a 14%
increase in the number of words recalled from intake to exit [intake 8.0 (3.0), exit 9.1 (3.5),
p<0.001].
Speed, Executive, Abstraction
Speed, executive functioning, and abstraction were assessed by the Digit Symbol, Trails-B,
CDT, FAS-OVF, and Similarities. The Digit Symbol is sensitive to psychomotor speed, and
there was a 2.1-unit improvement from intake to exit but was not statistically significant
[intake 8.2 (3.0), exit 9.0 (3.4), p=0.02]. The Trails-B which also is sensitive to psychomotor
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speed and working memory was not found to have statistically significant intake to exit
change [intake 99.9 (61.6), exit 96.1 (50.7), p = 0.426], but had an overall 4% decrease in the
number of seconds used to complete the task. For the CDT, which assesses visuoconstructive skills and executive functions, there was not a statistically significant intake to
exit change [intake 3.2 (0.9), exit 3.1 (0.9), p=0.603]. Furthermore, there was a statistically
significant intake to exit change in the FAS-OVF which assesses executive dysfunction
[intake 35.0 (12.1), exit 37.5 (12.9), p=0.001] and lastly, for Similarities which assesses
abstraction, there was not a statistically significant intake to exit change [intake 17.1 (5.9),
exit 17.3 (6.2), p=0.463].
Pre-morbid intellectual Functioning
Pre-morbid intellectual functioning measured by the NAART, the number of correct words
were analyzed from the number of errors made during the test with 36.5 (11.5) correct words
at intake 36.3 (11.5) and 36.7 (10.8) words at exit, p=0.535. This premorbid intellectual
functioning covariate remained the same from intake to exit.
In summary, from intake to exit CRSP there was statistically significant improvements in
depression, anxiety, physical health, verbal learning, memory, and executive functioning.
There were no changes in mental health-related quality-of-life, attention, and working
memory.

5.8 Exploratory Analyses
An ordinal logistic regression was used to assess whether a relationship exists between exit
DTS risk category and the number of exercise sessions attended. The assumption of
proportional odds was met, as assed by a full likelihood ratio test comparing the fit of the
proportional odds model to a model with varying location parameters, X2 (3) = 0.949,
p=0.813. The deviance goodness-of-fit test indicated that the model was a good fit to the
observed data, X2 (72) = 57.67, p=0.873. An increase in the number of exercise classes
attended was not associated with the odds of being in a particular DTS risk category at exit,
with an odds ratio of 0.99 (95% CI, 0.95, 1.03), Wald X2 (1) = 0.12, p =0.727. Table 9
outlines the results from the regression. Additionally, Figure 3 outlines the intake to exit
changes in DTS risk categories. Generally, the proportion of individuals in the high-risk
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category shifted from intake to exit with 24 (21%) participants in the high-risk category at
intake and 10 (9%) at exit – a statistically significant shift (p = 0.001). Participants shifted
into the moderate risk category with 65 (57%) at intake and 71 (62%) at exit. Lastly, there
was a 2% increase from intake to exit in the low risk category, with 9 (8%) participants in
this category at intake and 12 (10%) at exit.

5.9 Missingness
For baseline characteristics there was greater than 10 % missing data for the following
variables: employment status (17%), living situation (17%), NYHA functional classification
(14%), and CCS grading system of angina pectoris (14%). These missing variables were
mainly from the Ottawa sample because the data was not collected for those demographic
variables. Risk factor variables were relatively complete with no variables having greater
than 10% missing data. For baseline heath status measures DTS had greater than 15%
missing data. Maximal ST was primarily missing from the Ottawa CRSP program, therefore
DTS was unable to be calculated. For exercise attendance, there were 6 participants (5.2%)
that had missing attendance. Additionally, key CRSP outcomes that had greater than 10%
missing data were FBG (11%) and non-HDL-C (11%). In total 97 participants had complete
intake to exit data for all key CRSP variables, but a pairwise deletion was used for all
variables. Listwise deletion was also conducted and no major differences were found in the
results. These alternative analyses can be found in Appendix F.
Lastly, all of the psychometric variables had missing data greater than 10%. Specifically,
HADS-D (16%), HADS-A (11%), HADS-T (16%), SF12 (21%), MMSE (17%), NAART
(27%), Digits Forward and Backwards (17%), Trails-A (20%), Trails-B (20%), RAVLT
(16%), A6 and A7 (17%), Digit Symbol (17%), CDT (17%), and Similarities (29%). Only 53
participants had complete data for all psychometric variables, but pairwise deletion was used
as well. Analyses with listwise deletion were also conducted and minimal differences were
observed in the results. These alternative analyses can also be found in Appendix F.

5.10 Assessment of Potential Selection Bias
An assessment of potential selection bias was made between participants that completed
CRSP and included our present study versus participants that enrolled in CRSP but did not
complete the program. Of the 155 participants enrolled in CRSP, 115 completed the program.
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No significant differences were found in age (p=0.731), sex (p=0.584), ethnicity (p=1.0),
highest level of education (p=0.679), employment status (p=0.142), living situation
(p=0.747), NYHA functional classification (p=0.345), and CCS grading system of angina
pectoris (p=0.529). In terms of risk factors at intake, no significant differences were found in
sedentary lifestyle (p=0.238), family CVD history (0.189), diabetes (p=0.892), smoking
status (p=0.589), PMS (p=0.632), and BMI (p=0.369). A statistically significant difference
was found for dyslipidemia (p=0.002), and hypertension (p=0.016). For baseline health status
measures, no significant differences were found in HADS-D (p=0.652), HADS-A (p=0.129),
SF12-PCS (p=0.703), SF12-MCS (p=0.237), and DTS (p=0.265). Overall, selection bias was
not of concern. Detailed tables used to come to this conclusion are available in Appendix D.

5.11 Assessment of Non-response Bias
For demographic characteristic, there appeared to be non-response bias in employment status
and living situation, and this was primary observed in the Ottawa sample. This was due to the
variable not being measured. For our outcome measures, non-response was primarily of
concern in the psychometric variables as non-response was typically observed in those
variables. There were no differences in demographic characteristics between participants
with “known” vs. “unknown” values for the following variables: SF12, MMSE, RAVLT,
Digits, CDT, and Trails. For HADS-T the only observed difference between participants with
known HADS-T vs. unknown HADS-T was in the CCS class (p=0.03). For Similarities,
there were observed differences between participants that had known Similarities vs.
unknown Similarities in the study site (p<0.001), study type(p<0.001), employment status
(p<0.001), living situation (p<0.001), NYHA (p<0.001), and CCS (p<0.001). Overall, nonresponse bias is of concern for psychometric variables. Detailed tables used to come this
conclusion can be found in Appendix E.

5.12 Adverse Events
From the first pilot observational study, one subject had two TIAs without hospitalization,
two subjects had one TIA without hospitalization, one subject had carotid stent placement in
hospital, and one subject had unstable angina, with hospitalization and coronary angiography
two days later. Furthermore, one subject had a TIA without hospitalization before intake.
There were no recurrent strokes that occurred between CRSP intake and exit among the 80
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subjects from the first observational study. From the multicenter RCT, one subject had a
second stroke event during the program.
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Table 1: Baseline Characteristics
Characteristic at Baseline (n=115)

Mean (SD) or
Frequency N (%)a

Site
London
Ottawa

98 (85.2)
17 (14.8)

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Full-time
Part-time
Unemployed/Disability
Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner
With others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing
a

62 (53.9)
13 (11.3)
40 (34.8)
66 (10.2)
65 (56.5)
50 (43.5)
110 (95.7)
5 (4.3)

31 (27)
30 (26.1)
16 (13.9)
33 (28.7)
5 (4.3)
39 (33.9)
6 (5.2)
6 (5.2)
45 (39.1)
19 (16.5)
26 (22.6)
67 (58.3)
3 (2.6)
19 (16.6)
81 (70.4)
13 (11.3)
5 (4.3)
16 (13.9)
94 (81.7)
4 (3.5)
1 (0.9)
16 (13.9)

Percentages for some characteristics may not equal 100% due to rounding error.

47
Table 2: Risk Factors at Intake
Risk Factor
Sedentary lifestyle

Mean (SD) or
Frequency N (%)a
67 (58.3)

Dyslipidemia
Missing

91 (79.1)
2 (1.7)

Hypertension

89 (77.4)

Family cardiovascular disease
history

48 (41.7)

Coronary artery disease history
Missing

11 (9.6)
39 (33.9)

Diabetes
Type 1
Type 2

30 (26.1)
2 (0.1)
28 (93.3)

Smoking history
Current smoker
Former smoker
Never smoked
Not obtained/missing

17 (14.8)
55 (47.8)
42 (36.5)
1 (0.9)

Post-menopausal Syndrome
Females (n=49)
Missing

27 (23.5)
27 (55.1)
1 (0.9)

Mean BMI (n = 114)
29.8 (4.9)
BMI > 25
93 (80.9)
Missing
1 (0.9)
a
Percentages for some characteristics may not equal 100% due to rounding error.
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Table 3: Baseline Health Status Measures
Psychometric

Mean (SD) or
Frequency N (%)a

Depression and Anxiety at intake (n=115)
HADS-D ≥ 8 (n=111)
Missing
HADS-A ≥ 8 (n=113)
Missing

18 (15.7)
4 (3.5)
29 (25.2)
2 (1.7)

HADS-Total ≥ 14 (n=111) 23 (20.0)
Missing

4 (3.5)

Quality of Life (n = 105)

a

SF-12 PCS

43.6 (9.8)

SF-12 MCS

51.4 (8.9)

Duke Treadmill Score (n =98)

-5.8 (7.3)

Duke Treadmill Score Risk
Category (n=98)
Low Risk
Moderate Risk
High Risk
Missing

9 (7.8)
65 (56.5)
24 (20.9)
17 (14.8)

Percentages for some characteristics may not equal 100% due to rounding error.
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Table 4: Exercise Attendance Summary (n=115)

a

Number of Classes Attended

Frequency N (%)a

1 to 10

7 (6.0)

11 to 20

12 (10.3)

21 to 30

20 (17.3)

31 to 40

42 (36.3)

41 to 50

26 (22.6)

> 50

2 (1.8)

Missing

6 (5.2)

Percentages for some characteristics may not equal 100% due to rounding error.
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Table 5: Regression Analyses for the Association between Exercise Attendance and
Functional Capacity (METS) at Exit (n=102)
Variable
Attendance
Intake
METS
R2

B
-0.00

Crude Model
SE
95% CI
0.03
-0.06, 0.05

Variable
Attendance
Intake
METs
Sex (male)
Age (years)
Sedentary
Lifestyle
R2

B
0.06
0.90

0.00
Adjusted Model
SE
95% CI
0.01
0.03, 0.09
0.07
0.77, 1.03

-0.33
-0.05
0.72

0.32
0.02
0.32

-0.97, 0.30
-0.08, -0.01
0.08, 1.36
0.75
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Table 6: Intake Versus Exit Mean Scores – Key CRSP Outcomes
Outcome

n

METs

109

Intake
Mean (SD)
6.5 (2.7)

Exit
Mean (SD)
8.3 (3.0)

Change
Units (%)
1.8 (27.6)

P Value
<0.001*

Effect
Size
0.9

TC, mmol/L

103

4.3 (1.3)

4.0 (2.7)

-0.3 (-6.3)

0.006*

0.3

LDL-C,

103

2.2 (1.0)

2.0 (0.9)

-0.2 (-8.6)

0.014

0.3

103

1.3 (0.4)

1.4 (0.4)

0.1 (4.5)

0.480

0.3

Non-HDL-C

102

3.4 (1.1)

3.0 (1.0)

-0.3 (9.8)

<0.001*

0.5

TG, mmol/L

103

1.6 (1.4)

1.3 (0.7)

-0.3 (-18.5)

0.004*

0.3

FBG, mmol/L

102

5.9 (1.6)

5.9 (1.4)

-0.0 (0.0)

0.909

0.0

SBP, mm Hg

108

133.1 (17.8)

130.9 (15.5)

-2.2 (-1.6)

0.233

0.1

DBP, mm Hg

108

79.3 (8.8)

76.5 (8.1)

-2.8 (-3.5)

0.004*

0.3

WC, cm

108

101.3 (12.6)

98.9 (11.8)

-2.4 (-2.4)

<0.001*

0.5

BMI, kg/m2

108

29.7 (4.9)

29.1 (4.7)

-0.6 (-2.0)

<0.001*

0.4

Body weight,

110

83.9 (14.8)

82.2 (14.4)

-1.8 (-2.1)

<0.001*

0.4

mmol/L
HDL-C
mmol/L

kg
* Statistically significant p-values; SD = standard deviations;
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Table 7: Intake Versus Exit Mean Scores – Psychometric Domains
Outcome

n

Intake

Exit

Change,

Mean (SD)

Mean (SD)

Units (%)

P Value

Effect
Size

HADS-D, points

97

3.5 (3.0)

2.3 (2.8)

-1.2 (-33.8)

<0.001*

0.5

HADS-A, points

102

5.3 (3.6)

4.2 (3.4)

-1.1 (-21.1)

<0.001*

0.4

HADS-T, points

97

8.9 (5.7)

6.6 (5.5)

-2.3 (-25.3)

<0.001*

0.6

SF12 - MCS

91

51.4 (9.2)

53.3 (11.4)

2.0 (3.9)

0.121

0.2

SF12 - PCS

91

43.6 (10.0)

47.1 (10.3)

3.5 (8.0)

0.001*

0.3

MMSE, points

96

28.2 (1.6)

28.2 (1.9)

0.1 (0.3)

0.669

0.0

NAART, correct

84

36.3 (11.5)

36.7 (10.8)

0.3 (0.9)

0.535

Dig-Fwd, raw

96

7.9 (2.4)

8.2 (2.4)

0.2 (2.9)

0.246

0.2

96

6.5 (2.4)

6.3 (2.6)

-0.2 (-3.1)

0.303

0.1

95

44.0 (13.7)

46.1 (13.1)

2.1 (4.6)

0.020

0.2

Similarities

82

17.1 (5.9)

17.3 (6.2)

0.3 (1.9)

0.463

0.0

Trails-A, s

92

39.3 (27.0)

36.2 (16.2)

-3.1 (-7.9)

0.164

0.2

Trails-B, s

92

99.9 (61.6)

96.1 (50.7)

-3.8 (-3.8)

0.426

0.1

RAVLT, words;

97

42.0 (8.6)

46.2 (10.3)

4.1 (9.8)

<0.001*

0.7

A6

96

8.2 (3.0)

9.0 (3.4)

0.8 (9.9)

0.001*

0.3

A7

95

8.0 (3.0)

9.1 (3.5)

1.1 (14.3)

<0.001*

0.6

Clock-drawing,

96

3.2 (0.9)

3.1 (0.9)

-0.1 (-1.6)

0.603

0.1

96

35.0 (12.1)

37.5 (12.9)

2.9 (8.3)

<0.001*

0.3

points
Dig-Back, raw
points
Dig-Sym, raw
points

sum A1-5

points
FAS-OVF, words

* Statistically significant p-values; SD = standard deviations
Note: A greater exit measure compared to intake measure represents improvement for that
outcome. This is observed for all variables except for HADS, MMSE, and Trails.
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Table 8: Number of Subjects Meeting Targets at Intake Versus Exit
Outcome
METs

≥7.0

Intake Frequency
(%)
42/115 (36.5)

TC, mmol/L

<4.0

59/113 (52.2)

56/104 (53.8)

1.000

LDL-C, mmol/L

<2.0

54/113 (47.8)

64/104 (61.5)

0.005*

HDL-C mmol/L

>1.0

92/113 (81.4)

88/104 (84.6)

0.531

Non-HDL-C

<4.0

86/113 (76.1)

92/104 (88.5)

0.001*

TG, mmol/L

<1.8

83/113 (73.5)

88/104 (84.6)

0.043*

FBG, mmol/L

<6.0

76/112 (67.9)

69/104 (66.3)

0.664

SBP, mm Hg

<140

69/114 (60.5)

68/109 (62.4)

0.742

DBP, mm Hg

<90

92/114 (80.7)

101/109 (92.7)

0.007*

Males <102;

29/64 (45.3)

32/64 (50.0)

0.595

Females <88

10/49 (20.0)

11/46 (22.0)

0.681

BMI, kg/m2

<25

21/114 (18.4)

24/109 (22.0)

0.250

HADS-D

<8

93/111 (80.9)

92/99 (92.9)

0.039*

HADS-A

<8

84/113 (73.0)

88/103 (76.5)

0.064

HADS-Total

< 14

88/111 (79.3)

90/99 (90.9)

<0.001*

WC, cm

Target

*Statistically Significant

Exit Frequency
(%)
71/109 (65.1)

P value
<0.001*
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Table 9: Ordinal Logistic Regression Analyses for the Relationship between Duke
Treadmill Risk Category at Exit and Exercise Attendance (n=93)
B

SE

Exit DTS Risk Category 1 (Low)

-2.16

0.79 0.12

0.03, 0.54

Exit DTS Risk Category 2 (Low and Moderate)

1.87

0.77 6.48

1.41, 29.68

-0.01

0.02 1.00

0.95, 1.03

Parameter

Odds
Ratio

95% CI

Threshold

Attendance
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Figure 2. Intake and Exit Distributions for Functional Capacity (METS)
1 MET = 3.5 ml/kg/min O2 consumption.
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Figure 3. Intake to Exit Changes in Duke Treadmill Score Risk Categories
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Chapter 6
6. Discussion
This chapter includes a brief overview in section 6.1 and then section 6.2 provides
interpretations for the main study findings. Section 6.3 outlines the study strengths and
limitations, while Section 6.4 includes study conclusions and future directives.

6.1 Overview
To the best our knowledge, this is the first study to examine the relationship between exercise
adherence and functional capacity among TIA/MNDS stroke survivors in CRSP. The
objectives for this study were: 1) quantify the relationship between exercise adherence and
functional capacity at CRSP program exit among exercise trained TIA/MNDS patients, 2a)
determine whether CRSP programming among exercise trained TIA/MNDS patients results
intake to exit improvements in exercise capacity, blood pressure, lipid profile, blood glucose,
body measurements and composition; and 2b) determine whether CRSP programming among
exercise trained TIA/MNDS patients results in significant intake to exit changes in the
following psychometric domains: quality of life and health status, anxiety, depression,
general cognitive impairment, attention and working memory, verbal learning and memory,
pre-morbid intellectual functioning, and speed/executive/abstraction.

6.2 Interpretation of Main Study Findings
6.2.1 Baseline Characteristics, Risk Factors and Health Status
Measures
Our selected sample was at high risk of recurrent vascular events due their index event as
well as most of them being overweight, having a sedentary lifestyle, a history of smoking, as
well as being hypertensive and hyperlipidemic. About 53% of our sample reported their
highest level of education as less than high school or graduated high school. Educational
attainment is a commonly used measure of SES suggesting that the majority of our sample
had low SES - an important risk factor for TIA, stroke, and CVD. Only a small subset (8%)
of our sample were in the DTS low risk category, suggesting most of our sample had a
predicted five-year mortality rate of 10% (moderate risk) or 35% (highest risk category).
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The average participant age for our selected sample was 66 years which was similar to other
studies with TIA/MNDS samples that also had an average age over 60 years (15,57–60,64).
From the 155 participants that enrolled in the facility-based exercise program, 115 (74.2%)
participants completed CRSP which is slightly greater than reported CRSP completion rates
for TIA (65) and cardiac patients (118). The 115 participants enrolled in the facility-based
exercise option attended on average 66% of the standard 50 sessions, which is slightly lower
than other studies that have reported exercise session attendance rates of 73% (65), 84% (64),
94% (16) but those studies had smaller sample sizes and some of them were of shorter
duration (e.g. 8 weeks). It is possible due to our mean time spent in our CRSP program being
8.5 months, participant adherence may have decreased over time.
At intake, 15.7% and 25.2% of the participants screened positive for depression and anxiety
respectively, illustrating the clinical importance of screening for depression and anxiety after
TIA/MNDS. Our findings and other findings in the literature (49,50,52,53) suggest that 8%
to 17% and 14% to 23% of patients would screen positively for depression and anxiety post
TIA/MNDS. Our findings confirm the high risk of post TIA depression and anxiety and
justifies the greater need to pay attention to these psychological outcomes in this patient
population. This patient population had a lower physical health status compared to the
average score of 50 (10) in the US population (94). Specifically, at intake, the participants
average SF-12 physical composite score was 43.6, while the mental composite score was
51.3. A lower intake physical composite score would suggest that our sample may have had
issues in physical functioning, role functioning, bodily pain, and general health vitality.
These limitations could have influenced CRSP participation. Furthermore, their mental health
status was comparable to the average national norm of 50 (10) in the US population.

6.2.3 Objective One
The results of the present study showed there is a “dose-response-like” relationship between
the number of exercise classes attended and functional capacity at exit. Specifically, for every
10 exercise classes, there was a predicted increase of 0.6 METS. The Canadian
Cardiovascular Society developed quality indicators for CRSP, and one of the top 5 quality
indicators is an ‘increase in exercise capacity’ (118). Specifically, an increase of 0.5 METS
in the participants exercise capacity from the initial to the final exercise session (119). Our
study was unique in that it investigated the number of exercise classes attended in CRSP and
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how they relate to functional capacity in TIA/MNDS patients and our findings demonstrate
the potential benefits of TIA/MNDS patients completing a CRSP exercise program and
achieving the CCS quality indicator exercise capacity increase of > 0.5 METS. Our findings
have potential implication on exercise prescription guidelines and informing “dose” in CRSP
for TIA/MNDS patients. Additionally, they demonstrate that the quality indicators developed
for assessing the quality of CRSP programming for other cardiovascular diseases may also be
used in this patient population.
On average, the participants attended 33 (12.0) exercise sessions or 66% of the 50 typically
prescribed sessions. Post hoc analysis of the difference in the number of exercise classes
attended between subjects that achieved a 0.5 MET increase vs subjects that did not, found
that subjects that achieved a 0.5 MET increase had a mean of 35 (9.6) exercise classes
attended, compared to subjects that did not achieve a 0.5 MET increase that had a mean
attendance of 25 (14.9) classes attended – a significant difference. This finding is similar to a
recent real-world CRSP outcome study of cardiac patients where CRSP completers that
achieved at least a 0.5 MET increase in exercise capacity attended a median of 32 supervised
exercise sessions (IQR = 21-41) compared to 25 (5-37) exercise training sessions for CRSP
completers who did not achieve a 0.5 MET increase (120). These findings suggest that
exercise attendance is integral in the improvement of functional capacity in CRSP.

6.2.4 Objective Two
From CRSP intake to exit, this sample demonstrated improvements in functional capacity
and other key risk-mediating outcomes. For functional capacity, we observed a mean
increase during cardiac rehabilitation programming of 1.8 METS (28%) which is greater than
0.5 METS (CCS quality indicator). Our results align with other studies having reported
significant improvements in functional capacity measured in METS (63) and peak VO2
(16,64–66,68)(16,63–65,67)(15,62–64,66). Specifically, only 37% of the subjects met the
METS target of ≥7.0 METS at intake, which improved to 65% of subjects meeting this target
at exit. Overall, we found improvements in the participants lipid profile (TC, non-HDL-C,
and TG), a protective effect (18). More subjects met the LDL-C, non-HDL-C, and TG
targets from intake to exit. For lipid profile, there is inconsistency in the literature with
regards to improvement in participant’s lipid profiles. Faulkner et al., (2013) found that
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TIA/MNDS patients enrolled in an 8-week health enhancing physical activity program had
significant baseline to post-intervention decrease in TC as well, but other studies did not find
improvements in participants lipid profiles (TC, LDL, HDL, TG) for participants enrolled in
a CRSP 10-week program (72).
Further, we found improvements in blood pressure, specifically DBP. These findings are also
inconsistent in the literature with studies demonstrating improvements in SBP but not DBP
(16,65), and no improvements in either SBP or DBP (72). Additionally, we observed
favorable improvements in BMI, WC, and weight. Although, the changes were small (~2%
reduction), these are usually the more difficult risk factors to improve in CRSP, but have also
been observed in other studies with stroke patients (65,72). Considering, approximately 81%
of our sample was overweight, weight loss is likely to lead to clinically important health
benefits (121). Lastly, we did not observe a change in FBG, this is likely due to having a
small subset of our sample being diabetic. Overall, the inconsistencies across studies are
likely due to the variability in the CRSP program components (study type, duration, number
of prescribed exercise sessions, and completion rates). Overall, our findings show an overall
improvement in the participants cardiovascular disease risk profile.
Additionally, mean depression and anxiety scores decreased significantly, suggesting
improved emotional functioning in this sample. Screening for depression decreased from
16% to 7% of participants screening positive for depression. A similar trend was observed
for anxiety with a decrease from 25% to 15%. Improvements in depression post TIA/MNDS
and stroke have also been reported (65,66). Average PCS (physical health status) improved
from intake to exit suggesting fewer physical limitations at exit. Other studies also reported
improved physical functioning as part of the SF-36-PCS (70), and also observed
improvements in subjects’ PCS (69). Mean RAVLT, A6, and A7 increased from intake to
exit suggesting improvements in verbal learning and memory. Additionally, improvements in
executive functioning were observed from the increase in FAS-OVF. These favourable
results work towards resolving some deficits of cognitive functioning after TIA that could
impact one’s ability to learn, understand new information, and apply health behaviours to
their lives intended to reduce vascular risk factors.
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We did not observe improvements in mental health status, general cognitive impairment,
attention, and working memory. For general cognitive impairment, it is possible that the
observed results were influenced by the measurement tool used. A systematic review
investigating, prevalence of cognitive impairment following TIA and minor stroke reported
variable increasing prevalence of 17%, 39%, and 54% using MMSE, NTB, and MoCA
respectively (38). Our neutral findings regarding CRSP and mental health status are
inconsistent with other findings in the literature. A RCT found significant improvements in
mental health and MCS summary score (70), while another RCT did not observe such
improvements (69). Our hypothesis that CRSP would improve all psychometrics cannot be
fully supported with our findings, and the inconsistencies in these psychometric domains
merit further study.

6.2.5 Exploratory Analyses
The exploratory analyses to assess whether there was a relationship between exit DTS risk
category and number of exercise sessions attended, did not find an association between the
two variables. Interestingly, it was observed that the proportion of individuals in the high risk
DTS category improved significantly from CRSP intake to exit into lower mortality risk
categories, suggesting that some subjects’ prognosis changed quite favourably during cardiac
rehabilitation programming.

6.3 Study Strengths and Limitations
One of the main strengths of this study is that it is the first to our knowledge to investigate
CRSP exercise class attendance and its effects on functional capacity in TIA/MNDS patients.
Thus, this research addressed a gap in the literature by exploring dose-response relationships
for exercise attendance after TIA/MNDS. This provides useful guidance for policy makers
interested in providing CRSP services for patients post TIA/MNDS. Additionally, the present
study provides real-life participation of TIA/MNDS patients that are not typically represented
in established CRSP programs which is likely due to issues with funding. This research is
highly relevant for the current stroke prevention strategies as it provides further evidence of
how TIA/MNDS patients could benefit from CRSP. Our research adds to the body of
knowledge that could help support a mandate to include this patient population in this
established community-based program. Further, this study had nearly equal sex
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representation, and it comprehensively assessed key CRSP risk factors, psychological
profiles, and outcomes. These analyses were made possible by the London CRSP clinical
database that included numerous variables for assessment. Further this study exhibits
temporality, which makes it possible to suggest that the outcomes were impacted by the
intervention. Despite the positive aspects of this research, the present study does have some
limitations.
One of the main limitations of this study was the absence of a control group, therefore we
cannot make causal inferences. With this study design, there is no control over other nonCRSP elements that may have also been changing throughout the duration of the
intervention. Further limitations included missing data due to collection methods.
Specifically, some demographic characteristics were missing from the Ottawa sample, but
data for the primary objective had little missing data, therefore it likely had no influence on
those results. Missing psychometric data was of greater concern for analyses of the secondary
objective and this may have influenced the results obtained for these variables. Additionally,
our sample was largely Caucasian (96%), therefore our findings would not be generalizable
to non-Caucasian populations. Lastly, sample size was pre-determined due to the
retrospective nature of the study design, therefore it was not possible to calculate an optimal
sample size required for scientifically valid results.

6.4 Conclusions and Future Directives
To our knowledge, this is the first report to explore the effect of exercise attendance on
functional capacity for TIA/MNDS patients in CRSP. The results of this study demonstrated
a dose-response-like relationship between exercise attendance and functional capacity which
reached a clinically significant change. Further, exercise-trained TIA/MNDS patients had
significant improvements in key cardiovascular risk factors, depression, anxiety, physical
health, verbal learning, memory and executive functioning.
Future work should replicate these findings through a randomized controlled trial both within
London, Ottawa and within other CRSP programs to improve generalizability. Longer-term
impact of CRSP for these patients as well as cost-effectiveness analyses would also be
relevant and would add to the body of knowledge. Post-stroke psychological outcomes are
fairly under researched and the measures used are often variable, which merits further
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consistent study in this subject area. Additionally, neuro-psychological outcomes should be
employed after TIA as they may aid in the identification of cognitive deficits in this patient
population. Further research should also explore different aspects of exercise attendance such
as exercise type, duration, and intensity.
Additional work in this subject area could potentially have treatment relevance that would
have important implications for TIA/MNDS secondary prevention strategies. If we are able
to significantly mitigate the risk of recurrent stroke, measures to help improve participants
adherence will be integral for future stroke prevention plans. If future work illustrates that
enrolment in CRSP for this patient population is better than current stroke practice, that could
shift the allocation of resources for CRSP programs to revise the criteria for enrolment in
these programs. This research presents a unique and productive collaboration between
Cardiac Rehabilitation and Stroke Prevention Clinics. Being able to connect TIA/MNDS
patients to existing cardiac rehabilitation programs presents an opportunity to improve
overall service provision without having to reform Stroke Prevention Clinics to include
“CRSP-like” programming, a duplication of services which would likely be associated with
additional and unnecessary costs. Our findings suggest that breaking down the silos of
cardiac and stroke rehabilitation while implementing a “vascular rehabilitation” program
might be a more effective means of secondary disease prevention for cardiac and
cerebrovascular patients.
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Table 10: Exercise Attendance Breakdown
Number of Classes
Attended

Frequency Percent
1
5
8
9
12
13
15
17
18
19
20
21
23
24
25
27
28
29
30

2
1
2
2
2
1
2
2
2
2
1
1
4
2
3
2
3
3
2

1.7
0.9
1.7
1.7
1.7
0.9
1.7
1.7
1.7
1.7
0.9
0.9
3.5
1.7
2.6
1.7
2.6
2.6
1.7
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Table 10: Exercise Attendance Breakdown Continued
Number of Classes Frequency
Attended
31
3
32
4
33
2
34
5
35
5
36
1
37
5
38
6
39
6
40
5
41
4
42
2
43
1
44
6
45
4
46
3
48
4
50
2
54
1
60
1

Percent
2.6
3.5
1.7
4.3
4.3
0.9
4.3
5.2
5.2
4.3
3.5
1.7
0.9
5.2
3.5
2.6
3.5
1.7
0.9
0.9
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Table 11: Bonferroni Adjustments for Key CRSP Outcomes
Domain
Functional capacity

Variables
METS

Calculation P value
0.05 ÷ 1
0.05

Lipid profile

TC, LDL-C, HDL-C, non-HDL-C,

0.05 ÷ 5

0.01

TG
Glucose

FBG

0.05 ÷1

0.05

Blood pressure

SBP, DBP

0.05 ÷ 2

0.03

Body composition

WC, BMI, weight

0.05 ÷ 3

0.02

Table 12: Bonferroni Adjustments for Psychometric Domains
Domain
Depression and Anxiety

Variables
HADS-T, HADS-D, HADS-A

Calculation P value
0.05 ÷ 3
0.02

Quality-of-life

SF12-PCS, SF12-MCS

0.05 ÷ 2

0.03

General cognitive
impairment

MMSE

0.05 ÷ 1

0.05

Attention and working
memory

Digits-Fwd, Digits Back, Trails A

0.05 ÷ 3

0.02

Verbal learning and
memory

RAVLT sum, A6, A7

0.05 ÷ 3

0.02

Speed, executive,
abstraction

Digit-Sym, Trails B, CDT, FASOVF, Similarities

0.05 ÷ 5

0.01

Pre-morbid intellectual
functioning

NAART

0.05 ÷ 1

0.05
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Table 13: Primary Objective Regression Models
Model 1
SE
95% CI
0.03
-0.06, 0.05

Variable
Attendance
Intake
METS
R2

B
-0.00

Variable
Attendance
Intake
METS
Sex (male)
Age (years)
R2

B
0.05
0.95

Model 3
SE
95% CI
0.02
0.02, 0.08
0.06
0.83, 1.08

-0.20

0.33

Variable
Attendance
Intake
METs
Sex (male)
Age (years)
Sedentary
Lifestyle
R2

B
0.05
0.96

Model 2
SE
95% CI
0.02
0.03, 0.08
0.06
0.83, 1.08

0.00

0.71

-0.86, 0.46
0.71

Model 4
SE
95% CI
0.01
0.03, 0.09
0.07
0.74, 1.01

-0.29
-0.05

0.32
0.02

-0.93, 0.35
-0.08, -0.01
0.73

B
0.06
0.90

Model 5
SE
95% CI
0.01
0.03, 0.09
0.07
0.77, 1.03

-0.33
-0.05
0.72

0.32
0.02
0.32

-0.97, 0.30
-0.08, -0.01
0.08, 1.36
0.75

B
0.06
0.87
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Assessment of Potential Selection Bias
To compare the differences between participants that completed CRSP (completers) vs.
participants that did not complete CRSP (non-completers), Pearson chi-square test was used
for categorical variables, Fisher’s exact test was used when expected cell counts were small,
and independent samples t-test was used for continuous variables. Additionally, variables
NYHA and CCS were collapsed to increase cell counts. Tables 14 to Table 16 outline these
comparisons.
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Table 14: Baseline Characteristics - Completers vs. Non-completers
Completers
N = 115
Characteristic at Baseline

NonCompleters
N = 40
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

98 (85.2)
17 (14.8)

29 (72.5)
11 (27.5)

0.072*

62 (53.9)
13 (11.3)
40 (34.8)
66 (10.2)

19 (47.5)
1 (2.5)
20 (50.0)
67 (12.7)

0.203*

65 (56.5)
50 (43.5)

24 (61.5)
15 (28.5)

0.584*

110 (95.7)
5 (4.3)

37 (92.5)
1 (0.0)
2 (0.1)

1.00∼

31 (27)
30 (26.1)
16 (13.9)
33 (28.7)
5 (4.3)

12 (35.3)
12 (35.3)
2 (5.9)
8 (23.5)
6 (15.0)

0.697*

43 (37.3)
70 (60.1)
19 (16.5)

6 (15.0)
16 (40.0)
18 (45.0)

26 (22.6)
70 (60.8)
19 (16.5)

7 (17.5)
16 (40.0)
17 (42.5)

0.747*

81 (70.4)
13 (11.3)
5 (4.3)
0 (0.0)
16 (13.9)

16 (40.0)
4 (20.0)
2 (5.0)
0 (0.0)
18 (45.0)

0.345*

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Missing
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

0.731•

0.142*

94 (81.7)
19 (47.5)
4 (3.5)
2 (5.0)
1 (0.9)
1 (2.5)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
16 (13.9)
22 (55.0)
*Pearson Chi-Square | ∼ Fisher’s Exact test | • Independent Samples T-test

0.529*
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Table 15: Risk Factors at Intake - Completers vs. Non-completers

Risk Factor
Sedentary lifestyle

Completers
Non-Completers
(n = 115)
(n=40)
Mean (SD) or Frequency N (%)
67 (58.3)
19 (47.5)

Dyslipidemia
Missing

91 (79.1)
2 (1.7)

22 (55.0)
0 (0.0)

0.002*

Hypertension

89 (77.4)

23 (57.5)

0.016*

Family CVD history

48 (41.7)

12 (30.0)

0.189*

Diabetes
Type 1
Type 2

30 (26.1)
2 (0.1)
28 (93.3)

10 (25.0)

0.892*
0.224∼

Smoking history
Current smoker
Former smoker
Non-smokers
Not obtained/missing

17 (14.8)
55 (47.8)
42 (36.5)
1 (0.9)

6 (15.0)
13 (32.5)
15 (37.5)
6 (15.0)

Post-menopausal Syndrome
Females (n=49; n=15)
Missing

27 (23.5)
27 (55.1)
1 (0.9)

8 (20.0)
8 (53.3)
0 (0.0)

0.632*

Mean BMI (n = 114)
BMI > 25
Missing

29.8 (4.9)
93 (80.9)
1 (0.9)

28.9 (5.3)
24 (72.7)
0 (0.0)

0.369•
0.267*

P value
0.238 *

0.589*

*Pearson Chi-Square | ∼ Fisher’s Exact test | • Independent Samples T-test
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Table 16: Baseline Health Status Measures - Completers vs. Non-completers

Psychometric / Characteristic

Completers

Non-completers

N = 115

N = 40

P value

Mean (SD) or Frequency N (%)
Depression and Anxiety at intake
18 (15.7)

4 (10.0)

4 (3.5)

9 (22.5)

29 (25.2)

15 (38.5)

2 (1.7)

1 (0.0)

23 (20.0)

11 (27.5%)

4 (3.5)

9 (22.5)

43.6 (9.8)

42.8 (9.0)

10 (8.7)

9 (22.5)

51.4 (8.9)

46.7 (13.1)

10 (8.7)

9 (22.5)

Duke Treadmill Score

-5.8 (7.3)

-7.8 (6.3)

Duke Treadmill Score Risk Category
Low Risk
Moderate Risk
High Risk
Missing

9 (7.8)
65 (56.5)
24 (20.9)
17 (14.8)

1 (0.0)
9 (22.5)
8 (20.0)
22 (55.0)

HADS-D ≥ 8
Missing
HADS-A ≥ 8
Missing
HADS-Total ≥ 14
Missing

0.652*
0.129*
0.089*

Quality of Life
SF-12 PCS
Missing
SF-12 MCS
Missing

*Pearson Chi-Square | • Independent Samples T-test

0.703•

0.237•
0.265•

0.216*
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Assessment of Potential Non-Response Bias
To compare the differences between participants that had a known variable vs. participants
that did not respond, Pearson chi-square test was used for categorical variables, Fisher’s
exact test was used when expected cell counts were small, and independent samples t-test
was used for continuous variables. For comparisons where one of the groups had a sample
size of less than 30, the Welch’s t-test for independent means was used. Additionally,
variables NYHA and CCS were collapsed to increase cell counts. Table 17 to Table 28
outline these comparisons.
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Table 17: Comparison Between Participants with Known Employment Status vs.
Unknown Employment Status

Characteristic

Known
Unknown
Employment
Employment
Status
Status
N = 96
N = 19
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

96 (100)
0 (0.0)

2 (10.5)
17 (89.5)

<0.001∼

1 – Observational Study
2 – 1st RCT
3 – 2nd RCT

62 (64.6)
12 (12.5)
22 (22.9)

0 (0.0)
1 (5.3)
18 (94.7)

<0.000*

Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

66 (10.5)

67 (8.9)

0.482

50 (52.1)
46 (47.9)

15 (78.9)
4 (21.1)

0.031∼

92 (95.8)
4 (4.0)

1 (5.3)
18 (94.7)

0.000∼

31 (32.3)
22 (22.9)
14 (14.6)
25 (26.0)
4 (4.2)

0 (0.0)
8 (42.1)
2 (10.5)
8 (42.1)
1 (5.3)

0.304*

25 (26.0)
70 (72.9)
1 (1.0)

3 (15.8)
0 (0.0)
16 (84.2)

0.022∼

78 (81.3)
13 (13.5)
5 (5.2)
0 (0.0)
0 (0.0)

3 (15.8)
0 (0.0)
0 (0.0)
0 (0.0)
16 (84.2)

0.005~

91 (94.8)
4 (4.2)
0 (0.0)
1 (1.0)
0 (0.0)
0 (0.0)

3 (15.8)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
16 (84.2)

1.00∼

Study

*Pearson Chi-Square | ∼ Fisher’s Exact test | • Independent Samples T-test
Statistically significant values are bolded.
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Table 18: Comparison Between Participants with Known Living Situation vs. Unknown
Living Situation

Characteristic at Baseline

Living
Living
Situation
Situation
Known
Unknown
N = 97
N = 18
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

97 (100.0)
0 (0.0)

1 (5.6)
17 (94.4)

<0.000∼

62 (63.9)
12 (12.4)
23 (23.7)
65 (10.5)

0 (0.0)
1 (5.6)
17 (94.4)
68 (8.5)

<0.000∼

51 (52.6)
46 (47.4)

14 (77.8)
4 (22.2)

0.048*

91 (95.9)
4 (4.0)

14 (94.4)
1 (5.6)

0.527∼

31 (31.9)
23 (23.7)
14 (14.4)
1 (1.0)
4 (4.1)

0 (0.0)
7 (38.9)
2 (11.1)
8 (44.4)
1 (5.6)

0.006∼

45 (46.4)
51 (52.6)
1 (1.0)

0 (0.0)
0 (0.0)
18 (100.0)

< 0.000∼

79 (81.4)
13 (13.4)
5 (5.2)
0 (0.0)
0 (0.0)

1 (5.6)
0 (0.0)
0 (0.0)
0 (0.0)
17 (94.4)

< 0.000∼

92 (94.8)
4 (4.1)
0 (0.0)
1 (1.0)
0 (0.0)
0 (0.0)

2 (11.1)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
16 (88.9)

< 0.000∼

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

*Chi-Square test | ∼ Fisher’s Exact test |  Welch’s t-test for independent means
Statistically significant values are bolded.

0.240
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Table 19: Comparison Between Participants with Known SF12 vs. Unknown SF-12

Characteristic at Baseline

SF-12
SF-12
Known
Unknown
N = 95
N = 20
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

80 (84.2)
15 (15.8)

18 (90.0)
2 (10.0)

0.733∼

51 (53.7)
11 (11.6)
33 (34.7)
65 (9.7)

11 (55.0)
2 (10.0)
7 (35.0)
70 (11.9)

0.979*

53 (55.8)
42 (44.2)

12 (60.0)
8 (40.0)

0.730*

91 (95.8)
4 (4.4)

19 (95.0)
1 (5.0)

1.00∼

25 (26.4)
25 (26.3)
13 (13.7)
31 (32.7)
1 (1.1)

6 (30.0)
5 (25.0)
3 (15.0)
2 (10.0)
4 (20.0)

0.420 *

40 (42.1)
40 (42.2)
15 (15.8)

11 (55.0)
5 (25.0)
4 (20.0)

0.170*

19 (23.8)
57 (71.3)
4 (5.1)

7 (35.0)
10 (50.0)
3 (15.0)

0.232∼

65 (68.4)
12 (12.6)
4 (4.2)
0 (0.0)
14 (14.7)

16 (80.0)
1 (5.0)
1 (5.0)
0 (0.0)
2 (10.0)

0.575*

77 (81.0)
3 (3.2)
0 (0.0)
1 (1.0)
0 (0.0)
14 (14.7)

17 (85.0)
1 (5.0)
0 (0.0)
0 (0.0
0 (0.0)
2 (10.0)

0.840*

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

*Chi-Square test | ∼ Fisher’s Exact test |  Welch’s t-test for independent means
Statistically significant values are bolded.

0.055
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Table 20: Comparison Between Participants with Known HADS-T vs. Unknown
HADS-T

Characteristic at Baseline

HADS-T
HADS-T
Known
Unknown
N = 99
N = 16
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

0.704 ∼

85 (85.9)
14 (14.1)

13 (81.3)
3 (18.8)

53 (53.5)
13 (13.1)
33 (33.3)
65 (10.4)

9 (56.3)
0 (0.0)
7 (43.8)
68 (9.3)

58 (58.6)
41 (41.4)

7 (43.8)
9 (56.3)

0.267 *

94 (94.9)
5 (5.0)

16 (100.0)
0 (0.0)

1.00 ∼

27 (27.3)
24 (24.2)
15 (15.2)
30 (30.3)
3 (3.0)

4 (25.0)
6 (37.5)
1 (6.3)
3 (18.3)
2 (12.5)

0.198*

42 (42.5)
42 (42.5)
15 (15.2)

3 (18.8)
9 (56.3)
4 (25.0)

0.105*

24 (24.2)
59 (59.6)
1 (1.0)

2 (12.5)
11 (68.8)
3 (18.8)

0.504∼

74 (74.7)
5 (5.1)
0 (0.0)
0 (0.0)
14 (14.1)

5 (31.3)
5 (31.3)
0 (0.0)
0 (0.0)
6 (37.5)

0.073*

80 (80.8)
5 (5.1)
0 (0.0)
0 (0.0)
0 (0.0)
14 (14.1)

10 (62.5)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
6 (37.5)

0.033∼

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

*Chi-Square test | ∼ Fisher’s Exact test |  Welch’s t-test for independent means
Statistically significant values are bolded.

0.254
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Table 21: Comparison Between Participants with Known MMSE vs. Unknown MMSE

Characteristic at Baseline

MMSE
MMSE
Known
Unknown
N = 97
N = 18
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

0.729∼

83 (85.6)
14 (14.4)

15 (83.3)
3 (16.7)

54 (55.7)
11 (11.3)
32 (33.0)
66 (10.2)

8 (44.4)
2 (11.1)
8 (44.4)
65 (10.8)

53 (54.6)
44 (45.4)

12 (66.7)
6 (33.3)

0.344*

93 (95.9)
4 (4.0)

17 (94.4)
1 (5.6)

0.580∼

24 (24.7)
26 (26.8)
13 (13.4)
31 (31.9)
3 (3.1)

7 (38.9)
4 (22.2)
3 (16.7)
2 (11.1)
2 (11.1)

0.287∼

40 (41.3)
42 (43.3)
15 (15.5)

5 (27.8)
9 (50.0)
4 (22.2)

0.365*

21 (21.6)
60 (61.9)
16 (16.5)

5 (27.8)
10 (55.6)
3 (16.7)

0.541∼

69 (71.1)
11 (11.3)
4 (4.1)
0 (0.0)
13 (13.4)

8 (44.4)
4 (22.2)
0 (0.0)
0 (0.0)
6 (33.3)

0.103 ∼

79 (81.4)
4 (4.1)
0 (0.0)
1 (1.0)
0 (0.0)
13 (13.4)

11 (61.1)
1 (5.6)
0 (0.0)
0 (0.0)
0 (0.0)
6 (33.3)

0.499

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

*Chi-Square test | ∼ Fisher’s Exact test |  Welch’s t-test for independent means
Statistically significant values are bolded.

0.977
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Table 22: Comparison Between Participants with Known RAVLT Sum vs Unknown
RAVLT

Characteristic at Baseline

RAVLT Sum
RAVLT Sum
Known
Unknown
N = 97
N = 18
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

83 (85.6)
14 (14.4)

15 (83.3)
3 (16.7)

0.729

54 (55.7)
11 (11.3)
32 (33.0)
66 (10.2)

8 (44.4)
2 (11.1)
8 (44.4)
65 (10.8)

53 (54.6)
44 (45.4)

12 (66.7)
6 (33.3)

0.344*

93 (95.9)
4 (4.0)

17 (84.4)
1 (5.6)

0.580∼

24 (24.7)
26 (26.8)
13 (13.4)
31 (31.9)
3 (3.1)

7 (38.9)
4 (22.2)
3 (16.7)
2 (11.1)
2 (11.1)

0.287∼

40 (41.3)
42 (43.3)
15 (15.5)

4 (27.8)
9 (50.0)
4 (22.2)

0.365*

21 (21.6)
60 (61.9)
1 (1.0)

5 (27.8)
10 (55.6)
3 (16.7)

0.541∼

69 (71.1)
11 (11.3)
4 (4.1)
0 (0.0)
13 (13.4)

8 (44.4)
4 (22.2)
0 (0.0)
0 (0.0)
6 (33.3)

0.103 ∼

79 (81.4)
4 (4.1)
3 (1.0)
0 (0.0)
0 (0.0)
3 (13.4)

11 (61.1)
1 (5.6)
0 (0.0)
0 (0.0)
0 (0.0)
6 (33.3)

0.499

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

0.977

*Pearson Chi-Square test | ∼ Fisher’s Exact test |  Welch’s t-test for independent means
Statistically significant values are bolded.
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Table 23: Comparison Between Participants with Known Similarities vs Unknown
Similarities

Characteristic at Baseline

Similarities
Similarities
Known
Unknown
N = 83
N = 32
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

83 (100.0)
0 (0.0)

15 (46.9)
17 (53.1)

<0.001*

43 (51.8)
50 (48.2)
0 (0.0)
66 (10.6)

8 (25.0)
2 (6.3)
22 (68.8)
66 (9.4)

<0.001*

43 (51.8)
40 (48.2)

22 (68.8)
10 (31.3)

0.100*

80 (86.4)
3 (3.6)

30 (93.8)
2 (6.2)

0.617 ∼

24 (28.9)
21 (25.3)
12 (14.5)
23 (27.7)
3 (3.6)

7 (21.9)
9 (28.1)
4 (12.5)
10 (31.3)
2 (6.3)

0.784*

40 (48.2)
42 (50.6)
1 (1.2)

5 (15.6)
9 (28.2)
18 (56.3)

<0.001*

21 (25.3)
60 (72.3)
1 (1.2)

5 (15.6)
10 (31.3)
17 (53.1)

<0.001*

69 (81.9)
11 (13.3)
4 (4.8)
0 (0.0)
0 (0.0)

8 (25.0)
4 (12.5)
0 (0.0)
0 (0.0)
20 (62.5)

<0.001*

78 (94.0)
4 (4.8)
1 (1.2)
0 (0.0)
0 (0.0)
0 (0.0)

11 (34.4)
1 (3.1)
0 (0.0)
0 (0.0)
0 (0.0)
20 (62.5)

<0.001*

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

*Pearson Chi-Square | ∼ Fisher’s Exact test | • Independent Samples T-test
Statistically significant values are bolded.

0.903•
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Table 24: Comparison Between Participants with Known Digits vs Unknown Digits

Characteristic at Baseline

Digits
Digits
Known
Unknown
N = 97
N = 18
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

83 (85.6)
14 (14.4)

15 (83.3)
3 (16.7)

0.729∼

51 (55.7)
11 (11.3)
32 (33.0)
66 (10.2)

8 (44.4)
2 (11.1)
8 (44.4)
66 (10.8)

0.691*

53 (54.6)
44 (45.4)

12 (66.7)
6 (33.3)

0.344*

93 (95.9)
4 (4.0)

17 (94.4)
1 (5.6)

0.580∼

24 (24.7)
26 (26.8)
13 (13.4)
31 (31.9)
3 (3.1)

7 (38.9)
2 (22.2)
3 (16.7)
2 (11.1)
2 (11.1)

0.437*

40 (41.3)
42 (43.3)
15 (15.5)

5 (27.8)
9 (50.0)
4 (22.2)

0.365*

21 (21.6)
78 (80.4)
16 (16.5)

5 (27.8)
10 (55.6)
3 (16.7)

0.327*

69 (71.1)
11 (11.3)
4 (4.1)
0 (0.0)
13 (13.4)

12 (66.7)
2 (11.1)
1 (5.6)
0 (0.0)
3 (16.7)

0.714*

79 (81.4)
4 (4.1)
0 (0.0)
1 (1.0)
0 (0.0)
13 (13.4)

15 (83.3)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
3 (16.7)

0.716∼

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

0.978 

*Pearson Chi-Square test | ∼ Fisher’s Exact test |  Welch’s t-test for independent means
Statistically significant values are bolded.
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Table 25: Comparison Between Participants with Known CDT vs. Unknown CDT

Characteristic at Baseline

CDT
CDT
Known
Unknown
N = 97
N = 18
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

83 (85.6)
14 (14.4)

15 (83.3)
3 (16.7)

0.729∼

51 (55.7)
11 (11.3)
32 (33.0)
66 (10.2)

8 (44.4)
2 (11.1)
8 (44.4)
66 (10.8)

0.691*

53 (54.6)
44 (45.4)

12 (66.7)
6 (33.3)

0.344*

93 (95.9)
4 (4.0)

17 (94.4)
1 (5.6)

0.580∼

24 (24.7)
26 (26.8)
13 (13.4)
31 (31.9)
3 (3.1)

7 (38.9)
2 (22.2)
3 (16.7)
2 (11.1)
2 (11.1)

0.437*

40 (41.3)
42 (43.3)
15 (15.5)

5 (27.8)
9 (50.0)
4 (22.2)

0.365*

21 (21.6)
78 (80.4)
16 (16.5)

5 (27.8)
10 (55.6)
3 (16.7)

0.327*

69 (71.1)
11 (11.3)
4 (4.1)
0 (0.0)
13 (13.4)

12 (66.7)
2 (11.1)
1 (5.6)
0 (0.0)
3 (16.7)

0.714*

79 (81.4)
4 (4.1)
0 (0.0)
1 (1.0)
0 (0.0)
13 (13.4)

15 (83.3)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
3 (16.7)

0.716∼

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

0.978

*Pearson Chi-Square test | ∼ Fisher’s Exact test |  Welch’s t-test for independent means
Statistically significant values are bolded.
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Table 26: Comparison Between Participants with Known Trails vs. Unknown Trails

Characteristic at Baseline

Trails
Trails
Known
Unknown
N = 96
N = 19
Mean (SD) or Frequency N (%)

P value

Site
London
Ottawa

82 (85.4)
14 (14.6)

16 (84.2)
3 (15.8)

1.00∼

54 (56.3)
11 (11.5)
31 (32.3)
66 (10.1)

8 (42.1)
2 (10.5)
9 (47.4)
65 (11.0)

0.441*

53 (55.2)
43 (44.8)

12 (63.2)
7 (36.8)

0.523*

92 (95.8)
4 (4.0)

18 (94.7)
1 (5.3)

1.00 ∼

24 (25.0)
26 (27.1)
12 (12.5)
31 (32.3)
3 (3.1)

7 (36.8)
4 (21.1)
4 (21.1)
2 (10.5)
2 (10.5)

0.404*

39 (40.6)
42 (42.7)
15 (15.6)

6 (31.6)
9 (47.4)
4 (21.1)

0.561*

21 (21.9)
59 (61.5)
16 (16.6)

5 (26.3)
11(57.9)
3 (15.8)

0.760∼

68 (70.8)
11 (11.5)
4 (4.2)
0 (0.0)
13 (13.5)

13 (68.4)
2 (10.5)
1 (5.3)
0 (0.0)
3 (15.8)

1.00 ∼

78 (81.3)
4 (4.2)
0 (0.0)
1 (1.0)
0 (0.0)
13 (13.5)

16 (84.2)
0 (0.0)
0 (0.0)
0 (0.0)
0 (0.0)
3 (15.8)

0.727∼

Study
1 – Observational Study
2 – 1st RCT
3 – 2nd RCT
Age (years)
Sex
Male
Female
Ethnicity
White/Caucasian
Other
Highest Level of Education
Less than high school
Graduated high school
Some post-secondary
Graduated university/college
Not obtained/missing
Employment Status
Employed
Unemployed/Disability/Retired
Not obtained/missing
Living Situation
Alone
With spouse/partner/others
Not obtained/missing
NYHA Functional Classification
Class I
Class II
Class III
Class IV
Not obtained/missing
CCS Grading System of Angina Pectoris
Class 0
Class I
Class II
Class III
Class IV
Not obtained/missing

0.772

*Pearson Chi-Square test | ∼ Fisher’s Exact test |  Welch’s t-test for independent means
Statistically significant values are bolded.
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Appendix F: Alternative Analyses for Secondary Objectives
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Table 27: Objective 2A – Analyses Using Listwise Deletion (n = 97)
Outcome
METs

≥7.0

Intake Mean
(SD)
6.43 (2.8)

TC, mmol/L

<4.0

4.27 (1.2)

4.00 (1.1)

-0.27

0.006*

LDL-C, mmol/L

<2.0

2.22 (1.0)

2.01 (0.9)

-0.21

0.010

HDL-C mmol/L

>1.0

1.34 (0.4)

1.39 (0.4)

0.05

0.082

Non-HDL-C

<4.0

3.36 (1.0)

3.03 (0.9)

-0.33

<0.001*

TG, mmol/L

<1.8

1.56 (1.3)

1.32 (0.7)

-0.24

0.005*

FBG, mmol/L

<6.0

5.92 (1.6)

5.93 (1.3)

0.01

0.947

SBP, mm Hg

<140

132.82 (17.1)

130.96 (15.5)

-1.87

0.331

DBP, mm Hg

<90

79.02 (9.0)

76.28 (8.0)

-2.74

0.007*

Males

101.58 (12.6)

99.03 (11.8)

-2.55

<0.001*

WC, cm

Target

Exit Mean
(SD)
8.40 (3.1)

Change Units
(%)
1.97

P Value
<0.001*

<102;
Females
<88
BMI, kg/m2

<25

29.98 (4.9)

29.30 (4.7)

-0.68

<0.001*

Body weight, kg

n/a

84.38 (14.6)

82.48 (14.5)

-1.90

<0.001*

*Statistically Significant
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Table 28: Objective 2B – Analyses Using Listwise Deletion (n = 53)
Outcome

Intake Mean

Exit Mean

Change

P Value

(SD)

(SD)

Units

HADS-D, points

3.53 (3.3)

2.17 (2.9)

-1.36

<0.001*

HADS-A, points

5.75 (3.6)

4.23 (3.3)

-1.52

<0.001*

HADS-T, points

9.28 (6.0)

6.40 (5.5)

-2.89

<0.001*

SF12 - MCS

50.33 (10.4)

54.7 (7.6)

4.34

<0.000*

SF12 - PCS

44.30 (9.18)

47.83(10.2)

3.52

0.011*

MMSE, points

28.26 (1.3)

28.49 (1.7)

0.23

0.376

NAART, corr

35.84 (11.2)

36.38 (11.3)

0.53

0.221

Dig-Fwd, raw points

8.28 (2.1)

8.43 (2.5)

0.15

0.575

Dig-Back, raw points

6.55 (2.4)

6.25 (2.6)

-0.30

0.231

Dig-Sym, raw points

45.77 (12.7)

49.53 (11.6)

3.76

<0.001*

Similarities

18.00 (5.1)

18.47 (5.6)

0.47

0.391

Trails-A, s

35.17 (17.6)

31.55 (12.1)

-3.62

0.026

Trails-B, s

87.00 (46.9)

83.58 (43.1)

-3.40

0.435

RAVLT, words; sum

43.13 (8.6)

47.28 (10.2)

4.15

<0.001*

A6

8.26 (2.9)

9.04 (3.4)

0.77

0.021

A7

8.09 (2.8)

9.28 (3.5)

1.19

<0.001*

Clock-drawing, points

3.19 (0.9)

3.09 (1.0)

-0.09

0.489

38.62 (10.7)

41.92 (12.9)

3.30

0.010

A1-5

FAS-OVF, words
*Statistically Significant
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